Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper Genome Scanner VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:fluorobenzenes
go back to main search page
Accession:CHEBI:35496 term browser browse the term
Definition:Any fluoroarene that is a benzene or a substituted benzene carrying at least one fluoro group.

show annotations for term's descendants           Sort by:
 
1-hydroxymidazolam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases chemical synthesis ISO CYP3A5 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam CTD PMID:18191104 PMID:26958860 NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399 		JBrowse link
G Tspo translocator protein affects binding EXP 1-hydroxymethylmidazolam binds to TSPO protein; 1-hydroxymethylmidazolam metabolite binds to TSPO protein CTD PMID:7603229 NCBI chr 7:124,460,358...124,470,610
Ensembl chr 7:124,460,358...124,470,609 		JBrowse link
4-hydroxymidazolam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases chemical synthesis
multiple interactions		 ISO CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam
diosmetin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Luteolin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam]		 CTD PMID:18191104 NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399 		JBrowse link
azaperone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases activity ISO Azaperone results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253 		JBrowse link
bicalutamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aamp angio-associated, migratory cell protein increases expression ISO bicalutamide results in increased expression of AAMP mRNA CTD PMID:16631469 NCBI chr 9:81,560,836...81,566,642
Ensembl chr 9:81,560,842...81,566,642 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO bicalutamide results in decreased activity of ABCB11 protein CTD PMID:28437613 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 decreases activity ISO bicalutamide results in decreased activity of ABCB4 protein CTD PMID:28437613 NCBI chr 4:22,133,984...22,192,687
Ensembl chr 4:22,133,521...22,425,515 		JBrowse link
G Acp3 acid phosphatase 3 decreases expression ISO bicalutamide results in decreased expression of ACP3 mRNA CTD PMID:15638997 NCBI chr 8:112,838,574...112,884,062
Ensembl chr 8:112,834,707...112,884,077 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 increases expression ISO bicalutamide results in increased expression of ACSL1 mRNA CTD PMID:15790403 NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246 		JBrowse link
G Adam9 ADAM metallopeptidase domain 9 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ADAM9 protein] CTD PMID:17342749 NCBI chr16:71,810,377...71,887,926
Ensembl chr16:71,810,377...71,887,926 		JBrowse link
G Adrb2 adrenoceptor beta 2 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of ADRB2 mRNA; bicalutamide results in decreased expression of ADRB2 protein
bicalutamide inhibits the reaction [Triiodothyronine results in increased expression of ADRB2 protein]		 CTD PMID:18454446 NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834 		JBrowse link
G Agr2 anterior gradient 2, protein disulphide isomerase family member increases expression ISO bicalutamide results in increased expression of AGR2 mRNA CTD PMID:15638997 NCBI chr 6:55,465,782...55,487,087
Ensembl chr 6:55,465,782...55,487,714 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased phosphorylation of AKT1 protein] CTD PMID:17325745 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ALDH1A3 mRNA] CTD PMID:17526768 NCBI chr 1:127,302,920...127,337,828
Ensembl chr 1:127,301,128...127,337,882 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 increases expression ISO bicalutamide results in increased expression of ALDH3A2 mRNA CTD PMID:15638997 NCBI chr10:47,525,486...47,546,535
Ensembl chr10:47,525,493...47,546,345 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression ISO bicalutamide results in decreased expression of AMACR mRNA CTD PMID:15638997 NCBI chr 2:60,949,276...60,961,342
Ensembl chr 2:60,949,256...60,961,326 		JBrowse link
G Amd1 adenosylmethionine decarboxylase 1 increases expression ISO bicalutamide results in increased expression of AMD1 mRNA CTD PMID:15790403 NCBI chr20:45,384,000...45,399,694
Ensembl chr20:45,384,000...45,399,694 		JBrowse link
G Ankib1 ankyrin repeat and IBR domain containing 1 increases expression ISO bicalutamide results in increased expression of ANKIB1 mRNA CTD PMID:16631469 NCBI chr 4:27,473,477...27,597,206
Ensembl chr 4:27,473,477...27,597,206 		JBrowse link
G Ar androgen receptor decreases response to substance
decreases expression
multiple interactions
increases expression
decreases activity
affects binding
affects response to substance
affects localization		 ISO
EXP		 AR gene mutant form results in decreased susceptibility to bicalutamide; AR protein alternative form results in decreased susceptibility to bicalutamide
bicalutamide results in decreased expression of AR protein
bicalutamide binds to and results in decreased activity of AR protein; bicalutamide inhibits the reaction [[Testosterone binds to AR protein] inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]]
bicalutamide results in increased localization of and results in increased activity of AR protein
bicalutamide results in increased expression of AR; bicalutamide results in increased expression of AR protein
bicalutamide results in decreased expression of AR; bicalutamide results in decreased expression of AR mRNA
bicalutamide results in decreased activity of AR protein
[bicalutamide binds to AR protein] which binds to KLK3 promoter; bicalutamide binds to AR protein
AR protein affects the susceptibility to bicalutamide
[Azacitidine analog results in increased expression of AR protein] which results in increased susceptibility to bicalutamide; [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA]; [bicalutamide co-treated with Testosterone] affects the expression of and results in decreased activity of AR protein; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of and affects the localization of AR protein alternative form; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR mRNA; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR mRNA alternative form; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR protein; [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to PHB protein]; [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to SMARCA4 protein]; [Goserelin co-treated with bicalutamide] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of AR protein; AR protein promotes the reaction [bicalutamide promotes the reaction [PHB protein binds to KLK3 promoter]]; bicalutamide binds to and affects the localization of and affects the activity of AR protein; bicalutamide binds to and results in decreased activity of AR protein; bicalutamide binds to and results in increased activity of AR protein mutant form; bicalutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bicalutamide inhibits the reaction [[Dihydrotestosterone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; bicalutamide inhibits the reaction [[Metribolone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [AR protein alternative form binds to KLK3 promoter]; bicalutamide inhibits the reaction [AR protein alternative form promotes the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; bicalutamide inhibits the reaction [AR protein binds to KLK3 promoter]; bicalutamide inhibits the reaction [AR protein binds to NCOA1 protein]; bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to AR protein]]; bicalutamide inhibits the reaction [Cadmium Chloride results in decreased expression of AR mRNA]; bicalutamide inhibits the reaction [Cadmium Chloride results in decreased expression of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone affects the localization of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone binds to AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of AR mRNA]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of and results in increased phosphorylation of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; bicalutamide inhibits the reaction [Estradiol results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Estradiol results in increased activity of AR protein]; bicalutamide inhibits the reaction [Fludrocortisone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Flutamide results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Metribolone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Metribolone results in increased activity of AR protein]; bicalutamide inhibits the reaction [Metribolone results in increased folding of and results in increased stability of AR protein]; bicalutamide inhibits the reaction [OSM protein results in increased activity of AR protein]; bicalutamide inhibits the reaction [Sirolimus results in increased activity of AR protein]; bicalutamide inhibits the reaction [Testosterone results in increased activity of AR protein]; bicalutamide promotes the reaction [AR protein binds to KLK3 promoter]; bicalutamide promotes the reaction [AR protein binds to NCOR2 protein]; bicalutamide promotes the reaction [Niclosamide inhibits the reaction [AR protein binds to KLK3 promoter]]; bicalutamide promotes the reaction [Niclosamide results in decreased expression of AR protein alternative form]; bicalutamide promotes the reaction [Niclosamide results in decreased expression of AR protein]; methoxyacetic acid inhibits the reaction [bicalutamide inhibits the reaction [Testosterone results in increased activity of AR protein]]; mibolerone inhibits the reaction [bicalutamide results in increased expression of AR protein]; Resveratrol promotes the reaction [bicalutamide results in decreased activity of AR protein]
bicalutamide affects the localization of AR protein		 CTD PMID:10053169 PMID:11751618 PMID:11845989 PMID:11956172 PMID:11981028 PMID:12015321 PMID:12114440 PMID:12376534 PMID:12730620 PMID:12970580 PMID:15171712 PMID:15308689 PMID:15336702 PMID:15638997 PMID:15994348 PMID:16015592 PMID:16266977 PMID:16877366 PMID:17606915 PMID:17723170 PMID:17804755 PMID:18324645 PMID:18324785 PMID:18486176 PMID:18487222 PMID:18776922 PMID:18922931 PMID:19131511 PMID:19359544 PMID:19587329 PMID:20032058 PMID:20729295 PMID:21036700 PMID:21308717 PMID:21506597 PMID:23562765 PMID:23603339 PMID:24323034 PMID:24759320 PMID:25752796 PMID:26867867 PMID:27473015 PMID:27720946 PMID:28500234 PMID:28757136 PMID:29383186 PMID:29427707 PMID:29462692 PMID:33049310 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026 		JBrowse link
G Arg1 arginase 1 decreases expression ISO bicalutamide results in decreased expression of ARG1 protein CTD PMID:20711410 NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863 		JBrowse link
G Arg2 arginase 2 increases expression ISO bicalutamide results in increased expression of ARG2 protein CTD PMID:20711410 NCBI chr 6:102,311,097...102,338,406
Ensembl chr 6:102,311,116...102,338,520 		JBrowse link
G Asap2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 increases expression ISO bicalutamide results in increased expression of ASAP2 mRNA CTD PMID:16631469 NCBI chr 6:43,231,178...43,348,606
Ensembl chr 6:43,234,526...43,343,551 		JBrowse link
G Atf3 activating transcription factor 3 decreases expression
increases expression		 ISO bicalutamide results in decreased expression of ATF3 protein
bicalutamide results in increased expression of ATF3 mRNA		 CTD PMID:15638997 PMID:16516039 NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632 		JBrowse link
G Atp5me ATP synthase membrane subunit e increases expression ISO bicalutamide results in increased expression of ATP5ME mRNA CTD PMID:16631469 NCBI chr14:2,325,308...2,326,436
Ensembl chr14:2,325,308...2,326,436 		JBrowse link
G B4galt6 beta-1,4-galactosyltransferase 6 increases expression ISO bicalutamide results in increased expression of B4GALT6 mRNA CTD PMID:16631469 NCBI chr18:15,462,913...15,525,584
Ensembl chr18:15,462,913...15,525,579 		JBrowse link
G Bard1 BRCA1 associated RING domain 1 decreases expression ISO bicalutamide results in decreased expression of BARD1 mRNA CTD PMID:15638997 NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator decreases expression
increases expression
multiple interactions		 ISO bicalutamide results in decreased expression of BAX
bicalutamide results in increased expression of BAX protein
[bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of BAX protein; [Niclosamide co-treated with bicalutamide] results in increased expression of BAX protein; bicalutamide inhibits the reaction [Niclosamide results in decreased expression of BAX protein]		 CTD PMID:11845989 PMID:27132804 PMID:28500234 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207 		JBrowse link
G Bche butyrylcholinesterase decreases expression ISO bicalutamide results in decreased expression of BCHE mRNA CTD PMID:15638997 NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395 		JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression
multiple interactions		 ISO bicalutamide results in increased expression of BCL2
bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2 protein]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2 protein]		 CTD PMID:11845989 PMID:28500234 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374 		JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of BCL2L1 protein
bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2L1 protein]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2L1 protein]		 CTD PMID:28500234 NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO bicalutamide results in decreased expression of BIRC5 mRNA CTD PMID:15638997 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413 		JBrowse link
G Bnip3 BCL2 interacting protein 3 increases expression ISO bicalutamide results in increased expression of BNIP3 mRNA CTD PMID:15790403 NCBI chr 1:211,248,098...211,265,282
Ensembl chr 1:211,248,098...211,265,282 		JBrowse link
G Btbd3 BTB domain containing 3 increases expression ISO bicalutamide results in increased expression of BTBD3 mRNA CTD PMID:16631469 NCBI chr 3:131,330,338...131,360,554
Ensembl chr 3:131,351,587...131,357,929 		JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B decreases expression ISO bicalutamide results in decreased expression of BUB1B mRNA CTD PMID:15638997 NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO [bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of CASP3 protein; bicalutamide results in increased cleavage of and results in increased activity of CASP3 protein CTD PMID:15638997 PMID:27132804 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204 		JBrowse link
G Casp7 caspase 7 multiple interactions ISO bicalutamide promotes the reaction [Niclosamide results in increased expression of CASP7 protein modified form] CTD PMID:28500234 NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] CTD PMID:16317058 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870 		JBrowse link
G Ccna2 cyclin A2 decreases expression ISO bicalutamide results in decreased expression of CCNA2 mRNA CTD PMID:15887248 NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214 		JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO bicalutamide results in decreased expression of CCNB1 mRNA CTD PMID:15887248 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221 		JBrowse link
G Ccnb1ip1 cyclin B1 interacting protein 1 increases expression ISO bicalutamide results in increased expression of CCNB1IP1 mRNA CTD PMID:15638997 NCBI chr15:27,720,220...27,736,528
Ensembl chr15:27,720,223...27,733,785 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression		 ISO Niclosamide promotes the reaction [bicalutamide results in decreased expression of CCND1 protein] CTD PMID:28500234 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325 		JBrowse link
G Ccng2 cyclin G2 increases expression ISO bicalutamide results in increased expression of CCNG2 mRNA CTD PMID:15790403 NCBI chr14:16,267,572...16,276,068
Ensembl chr14:16,267,573...16,276,068 		JBrowse link
G Ccpg1 cell cycle progression 1 increases expression ISO bicalutamide results in increased expression of CCPG1 mRNA CTD PMID:15638997 NCBI chr 8:79,660,634...79,692,044
Ensembl chr 8:79,660,657...79,692,039 		JBrowse link
G Cd40 CD40 molecule multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 mRNA]] CTD PMID:16317058 NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704 		JBrowse link
G Cd9 CD9 molecule increases expression ISO bicalutamide results in increased expression of CD9 mRNA CTD PMID:15790403 NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166 		JBrowse link
G Cdc20 cell division cycle 20 decreases expression ISO bicalutamide results in decreased expression of CDC20 mRNA CTD PMID:15638997 NCBI chr 5:137,260,728...137,264,931
Ensembl chr 5:137,260,739...137,265,015 		JBrowse link
G Cdc6 cell division cycle 6 decreases expression ISO bicalutamide results in decreased expression of CDC6 mRNA; bicalutamide results in decreased expression of CDC6 protein CTD PMID:15887248 NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402 		JBrowse link
G Cdh1 cadherin 1 affects localization ISO bicalutamide affects the localization of CDH1 protein CTD PMID:17440980 NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression ISO bicalutamide results in decreased expression of CDK1 mRNA CTD PMID:15638997 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions		 ISO bicalutamide results in increased expression of CDKN1A; bicalutamide results in increased expression of CDKN1A mRNA; bicalutamide results in increased expression of CDKN1A protein
[bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of CDKN1A protein		 CTD PMID:11845989 PMID:15638997 PMID:27132804 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression ISO bicalutamide results in increased expression of CDKN1B CTD PMID:11845989 NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C decreases expression ISO bicalutamide results in decreased expression of CDKN2C mRNA CTD PMID:15638997 NCBI chr 5:129,347,731...129,352,886
Ensembl chr 5:129,347,732...129,352,886 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 decreases expression ISO bicalutamide results in decreased expression of CKS2 mRNA CTD PMID:15638997 NCBI chr17:13,587,664...13,593,423
Ensembl chr17:13,587,665...13,593,423 		JBrowse link
G Clgn calmegin increases expression ISO bicalutamide results in increased expression of CLGN mRNA CTD PMID:15638997 NCBI chr19:24,545,257...24,578,527
Ensembl chr19:24,545,318...24,576,798 		JBrowse link
G Clu clusterin multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of CLU mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased expression of CLU protein] CTD PMID:17148459 PMID:17325745 NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857 		JBrowse link
G Copb2 COPI coat complex subunit beta 2 increases expression ISO bicalutamide results in increased expression of COPB2 mRNA CTD PMID:16631469 NCBI chr 8:106,582,339...106,603,763 JBrowse link
G Crebbp CREB binding protein multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in decreased expression of CREBBP protein] CTD PMID:15378487 NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions EXP bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP11A1 protein]; bicalutamide inhibits the reaction [Testosterone results in increased expression of CYP11A1 protein] CTD PMID:21273442 NCBI chr 8:62,798,317...62,809,848
Ensembl chr 8:62,779,875...62,809,893 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions EXP bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP19A1 protein]; bicalutamide inhibits the reaction [Testosterone results in increased expression of CYP19A1 protein] CTD PMID:21273442 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA]; bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA] CTD PMID:23603339 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions EXP bicalutamide inhibits the reaction [[Testosterone binds to AR protein] inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]] CTD PMID:20032058 NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382 		JBrowse link
G Deptor DEP domain containing MTOR-interacting protein multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of DEPTOR mRNA] CTD PMID:26558456 NCBI chr 7:94,795,161...95,000,750
Ensembl chr 7:94,795,214...94,995,809 		JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO bicalutamide results in increased expression of DIO3 mRNA CTD PMID:15638997 NCBI chr 6:134,627,278...134,629,139
Ensembl chr 6:134,627,278...134,629,138 		JBrowse link
G Dkc1 dyskerin pseudouridine synthase 1 decreases expression ISO bicalutamide results in decreased expression of DKC1 mRNA CTD PMID:15638997 NCBI chr  X:155,844,914...155,862,363
Ensembl chr  X:155,844,857...155,862,475 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression ISO bicalutamide results in increased expression of DNAJB9 mRNA CTD PMID:15638997 NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151 		JBrowse link
G Drd4 dopamine receptor D4 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of DRD4 mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of DRD4 protein]		 CTD PMID:19587329 NCBI chr 1:214,278,296...214,282,818
Ensembl chr 1:214,278,296...214,281,483 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase decreases expression ISO bicalutamide results in decreased expression of EBP mRNA CTD PMID:15638997 NCBI chr  X:15,049,394...15,055,782
Ensembl chr  X:15,049,462...15,055,781 		JBrowse link
G Egf epidermal growth factor multiple interactions ISO bicalutamide inhibits the reaction [FOS protein results in increased expression of EGF mRNA] CTD PMID:15466214 NCBI chr 2:68,820,616...68,895,537 JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to AR protein]]; bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to ESR2 protein]]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of EGFR protein] CTD PMID:29383186 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of EIF4EBP1 protein CTD PMID:21036700 NCBI chr16:68,954,860...68,968,248
Ensembl chr16:68,954,875...68,968,248 		JBrowse link
G Eppin epididymal peptidase inhibitor decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of EPPIN mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of EPPIN protein]		 CTD PMID:19587329 NCBI chr 3:161,043,761...161,050,550
Ensembl chr 3:161,041,727...161,050,557 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO bicalutamide binds to and results in increased activity of ESR1 protein CTD PMID:33049310 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to ESR2 protein]] CTD PMID:29383186 NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251 		JBrowse link
G Etl4 enhancer trap locus 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of KIAA1217 mRNA] CTD PMID:17624924 NCBI chr17:87,173,265...87,681,268
Ensembl chr17:87,274,944...87,681,317 		JBrowse link
G Etv1 ETS variant transcription factor 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ETV1 mRNA] CTD PMID:28757136 NCBI chr 6:58,467,215...58,558,640
Ensembl chr 6:58,467,254...58,558,631 		JBrowse link
G Ezr ezrin multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of EZR mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased phosphorylation of EZR protein] CTD PMID:16873375 NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of FABP4 protein] CTD PMID:18801408 NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305 		JBrowse link
G Fgf13 fibroblast growth factor 13 increases expression ISO bicalutamide results in increased expression of FGF13 mRNA CTD PMID:15638997 NCBI chr  X:142,053,648...142,589,274
Ensembl chr  X:142,053,654...142,248,369 		JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 increases expression ISO bicalutamide results in increased expression of FKBP11 mRNA CTD PMID:15638997 NCBI chr 7:140,398,253...140,402,664
Ensembl chr 7:140,398,199...140,437,467 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of FKBP5 mRNA
[Niclosamide co-treated with bicalutamide] results in decreased expression of FKBP5 mRNA		 CTD PMID:28500234 NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of FOS mRNA]; bicalutamide inhibits the reaction [FOS protein results in increased expression of EGF mRNA] CTD PMID:15466214 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions ISO FSHB protein inhibits the reaction [bicalutamide results in decreased expression of DRD4 protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of EPPIN protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of GPD1 protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of RHOX5 protein] CTD PMID:19587329 NCBI chr 3:98,088,321...98,092,131
Ensembl chr 3:98,088,324...98,092,131 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression ISO bicalutamide results in increased expression of GADD45A mRNA CTD PMID:15638997 NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842 		JBrowse link
G Gcg glucagon decreases expression ISO bicalutamide results in decreased expression of GCG mRNA CTD PMID:15638997 NCBI chr 3:48,442,635...48,451,650
Ensembl chr 3:48,442,635...48,451,650 		JBrowse link
G Gpc1 glypican 1 decreases expression ISO bicalutamide results in decreased expression of GPC1 mRNA CTD PMID:15638997 NCBI chr 9:99,998,275...100,026,818
Ensembl chr 9:99,998,275...100,026,818 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of GPD1 mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of GPD1 protein]		 CTD PMID:19587329 NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928 		JBrowse link
G Gpnmb glycoprotein nmb increases expression ISO bicalutamide results in increased expression of GPNMB mRNA CTD PMID:15638997 NCBI chr 4:78,694,447...78,715,685
Ensembl chr 4:78,694,447...78,715,683 		JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A decreases expression ISO bicalutamide results in decreased expression of GPRC5A mRNA CTD PMID:15638997 NCBI chr 4:168,832,937...168,851,650
Ensembl chr 4:168,832,910...168,851,652 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions ISO bicalutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] CTD PMID:16496412 NCBI chr 6:41,932,941...42,002,770
Ensembl chr 6:41,932,244...42,002,819 		JBrowse link
G Gtpbp2 GTP binding protein 2 increases expression ISO bicalutamide results in increased expression of GTPBP2 mRNA CTD PMID:15638997 NCBI chr 9:17,198,957...17,208,456
Ensembl chr 9:17,198,957...17,209,220 		JBrowse link
G Hyou1 hypoxia up-regulated 1 increases expression ISO bicalutamide results in increased expression of HYOU1 mRNA CTD PMID:15638997 NCBI chr 8:48,699,796...48,711,912
Ensembl chr 8:48,699,769...48,711,910 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]] CTD PMID:16317058 NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions
increases expression		 ISO [bicalutamide co-treated with Tamoxifen] results in decreased expression of IGF1 protein; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of IGF1 mRNA]
bicalutamide results in increased expression of IGF1 mRNA; bicalutamide results in increased expression of IGF1 protein		 CTD PMID:16368782 PMID:16847815 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions ISO [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein CTD PMID:16847815 NCBI chr14:87,448,716...87,453,783
Ensembl chr14:87,448,692...87,453,785 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 multiple interactions
increases expression		 ISO
EXP		 bicalutamide promotes the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA]
bicalutamide results in increased expression of IGFBP2 mRNA		 CTD PMID:10604720 PMID:16368782 NCBI chr 9:80,118,029...80,144,804
Ensembl chr 9:80,118,029...80,144,789 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions
increases expression
decreases secretion
decreases expression		 ISO
EXP		 [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP3 protein
bicalutamide results in increased expression of IGFBP3 protein
bicalutamide results in increased expression of IGFBP3 mRNA
bicalutamide results in decreased secretion of IGFBP3 protein
bicalutamide results in decreased expression of IGFBP3 mRNA		 CTD PMID:10604720 PMID:16368782 PMID:16847815 NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 increases expression EXP bicalutamide results in increased expression of IGFBP4 mRNA CTD PMID:10604720 NCBI chr10:86,950,555...86,962,563
Ensembl chr10:86,950,557...86,962,578 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 increases expression EXP bicalutamide results in increased expression of IGFBP5 mRNA CTD PMID:10604720 NCBI chr 9:80,154,230...80,166,813
Ensembl chr 9:80,150,211...80,167,033 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO [IL6 protein results in increased expression of NCOA2 protein] which results in decreased susceptibility to bicalutamide; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [BCG Vaccine results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [IL6 protein results in increased expression of KLK3 mRNA] CTD PMID:11410519 PMID:14532843 PMID:16317058 PMID:19240160 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807 		JBrowse link
G Kif20a kinesin family member 20A decreases expression ISO bicalutamide results in decreased expression of KIF20A mRNA CTD PMID:15638997 NCBI chr18:27,424,328...27,432,814
Ensembl chr18:27,424,328...27,432,814 		JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 increases expression ISO bicalutamide results in increased expression of LAMP2 mRNA CTD PMID:16631469 NCBI chr  X:124,722,628...124,766,079
Ensembl chr  X:124,722,628...124,766,044 		JBrowse link
G Lamp3 lysosomal-associated membrane protein 3 increases expression ISO bicalutamide results in increased expression of LAMP3 mRNA CTD PMID:15638997 NCBI chr11:84,930,965...85,000,694
Ensembl chr11:84,972,132...85,000,681 		JBrowse link
G Lcn2 lipocalin 2 increases expression ISO bicalutamide results in increased expression of LCN2 mRNA CTD PMID:15638997 NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546 		JBrowse link
G Ldlr low density lipoprotein receptor affects localization ISO bicalutamide affects the localization of LDLR protein CTD PMID:17440980 NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903 		JBrowse link
G Lmnb1 lamin B1 decreases expression ISO bicalutamide results in decreased expression of LMNB1 mRNA CTD PMID:15638997 NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264 		JBrowse link
G LOC102549061 histone H2B type 1-N-like increases expression ISO bicalutamide results in increased expression of H2BC3 mRNA CTD PMID:15790403 NCBI chr17:43,627,872...43,628,518
Ensembl chr17:43,627,930...43,628,310 		JBrowse link
G Lrba LPS responsive beige-like anchor protein increases expression ISO bicalutamide results in increased expression of LRBA mRNA CTD PMID:15790403 NCBI chr 2:185,590,983...186,110,491
Ensembl chr 2:185,524,774...186,110,495 		JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 decreases expression ISO bicalutamide results in decreased expression of MAD2L1 mRNA CTD PMID:15638997 NCBI chr 4:97,530,993...97,543,179
Ensembl chr 4:97,531,083...97,537,086 		JBrowse link
G Man1a1 mannosidase, alpha, class 1A, member 1 increases expression ISO bicalutamide results in increased expression of MAN1A1 mRNA CTD PMID:15638997 NCBI chr20:35,257,688...35,450,132
Ensembl chr20:35,257,985...35,450,513 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein CTD PMID:15466214 NCBI chr 8:69,134,218...69,722,573
Ensembl chr 8:69,134,223...69,164,758 		JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K2 protein CTD PMID:15466214 NCBI chr 7:11,458,971...11,478,520
Ensembl chr 7:11,458,967...11,478,489 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein CTD PMID:15466214 PMID:29383186 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK3 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAPK3 protein CTD PMID:15466214 PMID:29383186 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975 		JBrowse link
G Mbd2 methyl-CpG binding domain protein 2 increases expression ISO bicalutamide results in increased expression of MBD2 mRNA CTD PMID:16631469 NCBI chr18:65,814,026...65,885,115
Ensembl chr18:65,814,026...65,885,114 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 decreases expression ISO bicalutamide results in decreased expression of MCM2 mRNA CTD PMID:15638997 NCBI chr 4:120,825,699...120,840,221
Ensembl chr 4:120,825,699...120,840,111 		JBrowse link
G Mdk midkine increases expression ISO bicalutamide results in increased expression of MDK mRNA CTD PMID:15638997 NCBI chr 3:80,841,003...80,843,895
Ensembl chr 3:80,841,005...80,842,916 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase multiple interactions ISO bicalutamide inhibits the reaction [Testosterone results in increased expression of MET mRNA] CTD PMID:11139396 PMID:17371283 NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665 		JBrowse link
G Mir21 microRNA 21 multiple interactions ISO bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [fludioxonil results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of MIR21 mRNA] CTD PMID:23052036 PMID:25969534 NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO bicalutamide results in decreased expression of MKI67 mRNA CTD PMID:15638997 NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454 		JBrowse link
G Mme membrane metallo-endopeptidase increases expression ISO bicalutamide results in increased expression of MME mRNA CTD PMID:15790403 NCBI chr 2:153,799,203...153,880,910
Ensembl chr 2:153,803,349...153,880,738 		JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions ISO bicalutamide inhibits the reaction [Androgens results in increased expression of MMP13 mRNA] CTD PMID:15138554 NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of MMP2 mRNA] CTD PMID:16888681 NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression
decreases expression		 ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of MYC mRNA; [Niclosamide co-treated with bicalutamide] results in decreased expression of MYC protein; bicalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of MYC mRNA]; Niclosamide inhibits the reaction [bicalutamide results in increased expression of MYC protein]
bicalutamide results in decreased expression of MYC mRNA		 CTD PMID:15638997 PMID:24759320 PMID:28500234 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240 		JBrowse link
G Myo6 myosin VI increases expression ISO bicalutamide results in increased expression of MYO6 mRNA CTD PMID:15790403 PMID:16631469 NCBI chr 8:87,583,649...87,731,271
Ensembl chr 8:87,630,916...87,731,269 		JBrowse link
G Ncoa1 nuclear receptor coactivator 1 multiple interactions ISO bicalutamide inhibits the reaction [AR protein binds to NCOA1 protein] CTD PMID:11981028 NCBI chr 6:28,677,563...28,931,844
Ensembl chr 6:28,677,540...28,931,843 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions ISO [IL6 protein results in increased expression of NCOA2 protein] which results in decreased susceptibility to bicalutamide CTD PMID:19240160 NCBI chr 5:5,466,544...5,696,540
Ensembl chr 5:5,616,483...5,694,598 		JBrowse link
G Ncor2 nuclear receptor co-repressor 2 multiple interactions ISO bicalutamide promotes the reaction [AR protein binds to NCOR2 protein] CTD PMID:11981028 NCBI chr12:36,871,917...37,033,701
Ensembl chr12:36,871,999...37,033,701 		JBrowse link
G Nebl nebulette increases expression ISO bicalutamide results in increased expression of NEBL mRNA CTD PMID:15638997 NCBI chr17:84,141,014...84,247,038
Ensembl chr17:84,140,489...84,488,601 		JBrowse link
G Nek2 NIMA-related kinase 2 decreases expression ISO bicalutamide results in decreased expression of NEK2 mRNA CTD PMID:15638997 NCBI chr13:110,511,546...110,524,750
Ensembl chr13:110,511,668...110,522,769 		JBrowse link
G Niban1 niban apoptosis regulator 1 increases expression ISO bicalutamide results in increased expression of NIBAN1 mRNA CTD PMID:15638997 NCBI chr13:68,949,665...69,101,600
Ensembl chr13:68,949,665...69,101,588 		JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions
decreases expression		 ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA; bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Cadmium Chloride results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]
bicalutamide results in decreased expression of NKX3-1 mRNA		 CTD PMID:11751618 PMID:15638997 PMID:28500234 PMID:29462692 NCBI chr15:51,065,316...51,067,908
Ensembl chr15:51,065,316...51,068,421 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO bicalutamide binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545 		JBrowse link
G Nrp1 neuropilin 1 decreases expression ISO bicalutamide results in decreased expression of NRP1 mRNA CTD PMID:15638997 NCBI chr19:61,332,351...61,486,166
Ensembl chr19:61,332,351...61,485,858 		JBrowse link
G Nts neurotensin decreases response to substance ISO NTS protein results in decreased susceptibility to bicalutamide CTD PMID:17044078 NCBI chr 7:44,111,594...44,120,998
Ensembl chr 7:44,111,151...44,121,130 		JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 decreases expression ISO bicalutamide results in decreased expression of NUSAP1 mRNA CTD PMID:15638997 NCBI chr 3:111,422,267...111,452,600
Ensembl chr 3:111,422,267...111,452,971 		JBrowse link
G Osm oncostatin M multiple interactions ISO bicalutamide inhibits the reaction [OSM protein results in increased activity of AR protein] CTD PMID:12114440 NCBI chr14:84,457,487...84,469,426
Ensembl chr14:84,465,515...84,470,409 		JBrowse link
G Pa2g4 proliferation-associated 2G4 multiple interactions
increases response to substance		 ISO bicalutamide promotes the reaction [PA2G4 protein binds to KLK3 promoter]
PA2G4 protein results in increased susceptibility to bicalutamide		 CTD PMID:15994225 NCBI chr 7:2,979,587...2,987,055
Ensembl chr 7:2,979,588...2,987,055 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO bicalutamide promotes the reaction [Niclosamide results in increased expression of PARP1 protein modified form] CTD PMID:28500234 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716 		JBrowse link
G Pbk PDZ binding kinase decreases expression ISO bicalutamide results in decreased expression of PBK mRNA CTD PMID:15638997 NCBI chr15:42,489,253...42,500,377
Ensembl chr15:42,489,377...42,500,395 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO bicalutamide results in decreased expression of PCNA mRNA CTD PMID:15638997 NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570 		JBrowse link
G Pds5b PDS5 cohesin associated factor B multiple interactions ISO bicalutamide inhibits the reaction [Calcitriol results in increased expression of APRIN] CTD PMID:15754350 NCBI chr12:659,995...794,042
Ensembl chr12:660,011...794,042 		JBrowse link
G Pecr peroxisomal trans-2-enoyl-CoA reductase increases expression ISO bicalutamide results in increased expression of PECR mRNA CTD PMID:15638997 NCBI chr 9:79,601,937...79,630,547
Ensembl chr 9:79,601,901...79,630,536 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO bicalutamide binds to and results in decreased activity of PGR protein CTD PMID:25752796 NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796 		JBrowse link
G Phb prohibitin multiple interactions ISO [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to PHB protein]; AR protein promotes the reaction [bicalutamide promotes the reaction [PHB protein binds to KLK3 promoter]]; bicalutamide promotes the reaction [PHB protein binds to KLK3 promoter]; PHB protein promotes the reaction [bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; PHB protein promotes the reaction [bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]] CTD PMID:18487222 NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878 		JBrowse link
G Pip prolactin induced protein decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of PIP mRNA
bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of PIP mRNA]		 CTD PMID:10402478 NCBI chr 4:71,320,859...71,325,153
Ensembl chr 4:71,320,859...71,325,153 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO bicalutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380 		JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression ISO bicalutamide results in decreased expression of PRC1 mRNA CTD PMID:15638997 NCBI chr 1:142,087,181...142,108,746
Ensembl chr 1:142,087,208...142,108,746 		JBrowse link
G Pten phosphatase and tensin homolog multiple interactions
increases activity		 ISO bicalutamide promotes the reaction [PTEN protein results in decreased expression of KLK3 mRNA]
bicalutamide results in increased activity of PTEN protein		 CTD PMID:16637073 NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] CTD PMID:16317058 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335 		JBrowse link
G Racgap1 Rac GTPase-activating protein 1 decreases expression ISO bicalutamide results in decreased expression of RACGAP1 mRNA CTD PMID:15638997 NCBI chr 7:141,277,303...141,308,849
Ensembl chr 7:141,277,312...141,307,233 		JBrowse link
G Ranbp1 RAN binding protein 1 decreases expression ISO bicalutamide results in decreased expression of RANBP1 mRNA CTD PMID:15638997 NCBI chr11:86,890,585...86,898,818
Ensembl chr11:86,890,585...86,898,818 		JBrowse link
G Rarb retinoic acid receptor, beta increases expression ISO bicalutamide results in increased expression of RARB mRNA CTD PMID:15790403 NCBI chr15:9,915,223...10,262,599
Ensembl chr15:10,120,206...10,262,599 		JBrowse link
G Rb1 RB transcriptional corepressor 1 increases phosphorylation ISO bicalutamide results in increased phosphorylation of RB1 protein CTD PMID:17599054 NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342 		JBrowse link
G Rom1 retinal outer segment membrane protein 1 increases expression ISO bicalutamide results in increased expression of ROM1 mRNA CTD PMID:15790403 NCBI chr 1:225,126,732...225,128,740
Ensembl chr 1:225,126,734...225,128,740 		JBrowse link
G Rps6 ribosomal protein S6 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of RPS6 protein CTD PMID:21036700 NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148
Ensembl chr 5:105,197,857...105,200,148 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of RPS6KB1 protein CTD PMID:21036700 NCBI chr10:73,824,200...73,865,503
Ensembl chr10:73,824,202...73,865,364 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 decreases expression ISO bicalutamide results in decreased expression of RRM2 mRNA CTD PMID:15638997 NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515 		JBrowse link
G Rxrb retinoid X receptor beta decreases expression ISO bicalutamide results in decreased expression of RXRB CTD PMID:11845989 NCBI chr20:3,822,673...3,829,138
Ensembl chr20:3,823,042...3,829,140 		JBrowse link
G Scgb2a1 secretoglobin, family 2A, member 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of SCGB2A1 mRNA] CTD PMID:16020486 NCBI chr 1:225,899,313...225,902,676
Ensembl chr 1:225,825,356...225,830,355
Ensembl chr 1:225,825,356...225,830,355 		JBrowse link
G Sem1 SEM1 26S proteasome subunit increases expression ISO bicalutamide results in increased expression of SEM1 mRNA CTD PMID:16631469 NCBI chr 4:32,067,444...32,087,600
Ensembl chr 4:32,067,444...32,087,600 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINE1 mRNA]] CTD PMID:16317058 NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 increases expression ISO bicalutamide results in increased expression of SLC3A2 mRNA CTD PMID:15638997 NCBI chr 1:224,906,566...224,921,029
Ensembl chr 1:224,906,554...224,921,092 		JBrowse link
G Slc4a4 solute carrier family 4 member 4 decreases expression ISO bicalutamide results in decreased expression of SLC4A4 mRNA CTD PMID:15638997 NCBI chr14:20,476,258...20,817,042
Ensembl chr14:20,479,323...20,920,286 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO bicalutamide results in increased expression of SLC7A11 mRNA CTD PMID:15638997 NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162 		JBrowse link
G Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 multiple interactions ISO [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to SMARCA4 protein]; bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]; PHB protein promotes the reaction [bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]] CTD PMID:18487222 NCBI chr 8:22,648,323...22,739,468
Ensembl chr 8:22,648,323...22,739,468 		JBrowse link
G Snap25 synaptosome associated protein 25 increases expression ISO bicalutamide results in increased expression of SNAP25 mRNA CTD PMID:15790403 NCBI chr 3:129,697,408...129,788,417
Ensembl chr 3:129,599,353...129,788,400 		JBrowse link
G Sord sorbitol dehydrogenase increases expression ISO bicalutamide results in increased expression of SORD mRNA CTD PMID:15790403 NCBI chr 3:114,176,127...114,207,368
Ensembl chr 3:114,176,309...114,207,366 		JBrowse link
G Spint2 serine peptidase inhibitor, Kunitz type, 2 increases expression ISO bicalutamide results in increased expression of SPINT2 mRNA CTD PMID:15790403 NCBI chr 1:87,199,373...87,221,826
Ensembl chr 1:87,199,313...87,221,892 		JBrowse link
G Sqstm1 sequestosome 1 increases expression ISO bicalutamide results in increased expression of SQSTM1 mRNA CTD PMID:15638997 NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294 		JBrowse link
G Stip1 stress-induced phosphoprotein 1 decreases expression ISO bicalutamide results in decreased expression of STIP1 mRNA CTD PMID:15638997 NCBI chr 1:222,274,133...222,293,139
Ensembl chr 1:222,274,133...222,293,148 		JBrowse link
G Tamm41 TAM41 mitochondrial translocator assembly and maintenance homolog increases expression ISO bicalutamide results in increased expression of TAMM41 mRNA CTD PMID:16631469 NCBI chr 4:146,922,085...146,954,159
Ensembl chr 4:146,922,085...146,954,159 		JBrowse link
G Tert telomerase reverse transcriptase decreases activity
decreases expression		 ISO bicalutamide results in decreased activity of TERT protein
bicalutamide results in decreased expression of TERT mRNA		 CTD PMID:15638997 NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476 		JBrowse link
G Thra thyroid hormone receptor alpha multiple interactions ISO bicalutamide binds to and results in increased activity of THRA protein CTD PMID:33049310 NCBI chr10:86,657,285...86,684,935
Ensembl chr10:86,657,285...86,684,933 		JBrowse link
G Thrb thyroid hormone receptor beta multiple interactions ISO bicalutamide binds to and results in increased activity of THRB protein CTD PMID:33049310 NCBI chr15:8,890,578...9,239,815
Ensembl chr15:8,890,578...9,086,282 		JBrowse link
G Tk1 thymidine kinase 1 decreases expression ISO bicalutamide results in decreased expression of TK1 mRNA CTD PMID:15638997 NCBI chr10:106,817,556...106,828,888
Ensembl chr10:106,817,601...106,828,884 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]] CTD PMID:16317058 NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052 		JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of TMEFF2 protein] CTD PMID:23405127 NCBI chr 9:55,379,130...55,673,704
Ensembl chr 9:55,384,100...55,673,829 		JBrowse link
G Tmprss2 transmembrane serine protease 2 multiple interactions ISO [Goserelin co-treated with bicalutamide] results in decreased expression of TMPRSS2 protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of TMPRSS2 protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of TMPRSS2 protein; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of TMPRSS2 mRNA] CTD PMID:23708653 PMID:24323034 PMID:28757136 NCBI chr11:38,063,914...38,103,406
Ensembl chr11:38,063,915...38,103,290 		JBrowse link
G Tmsb4x thymosin beta 4, X-linked multiple interactions
increases expression		 ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of TMSB4X mRNA]
bicalutamide results in increased expression of TMSB4X mRNA		 CTD PMID:17916567 NCBI chr  X:28,593,405...28,617,267
Ensembl chr  X:28,593,405...28,595,395 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] CTD PMID:16317058 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
Ensembl chr20:5,189,390...5,192,000 		JBrowse link
G Tp53 tumor protein p53 increases expression
multiple interactions		 ISO bicalutamide results in increased expression of TP53 protein
bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of TP53 protein]		 CTD PMID:15638997 PMID:29383186 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449 		JBrowse link
G Tp53i3 tumor protein p53 inducible protein 3 increases expression ISO bicalutamide results in increased expression of TP53I3 mRNA CTD PMID:15638997 NCBI chr13:75,101,759...75,145,967
Ensembl chr13:75,105,615...75,143,441 		JBrowse link
G Tpd52 tumor protein D52 decreases response to substance ISO TPD52 protein results in decreased susceptibility to bicalutamide CTD PMID:17875733 NCBI chr 2:94,959,732...95,041,277
Ensembl chr 2:95,008,311...95,040,514 		JBrowse link
G Tpx2 TPX2, microtubule nucleation factor decreases expression ISO bicalutamide results in decreased expression of TPX2 mRNA CTD PMID:15638997 NCBI chr 3:148,327,965...148,370,187
Ensembl chr 3:148,327,965...148,370,187 		JBrowse link
G Tram1 translocation associated membrane protein 1 increases expression ISO bicalutamide results in increased expression of TRAM1 mRNA CTD PMID:16631469 NCBI chr 5:5,215,196...5,297,337
Ensembl chr 5:5,215,196...5,316,685 		JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression ISO bicalutamide results in increased expression of TRIB3 mRNA CTD PMID:15638997 NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571 		JBrowse link
G Tyms thymidylate synthetase decreases expression ISO bicalutamide results in decreased expression of TYMS protein CTD PMID:17599054 NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564 		JBrowse link
G Uap1 UDP-N-acetylglucosamine pyrophosphorylase 1 increases expression ISO bicalutamide results in increased expression of UAP1 mRNA CTD PMID:15790403 NCBI chr13:88,463,532...88,497,901
Ensembl chr13:88,463,532...88,497,901 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C multiple interactions ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of UBE2C mRNA CTD PMID:28500234 NCBI chr 3:161,236,971...161,239,371
Ensembl chr 3:161,236,898...161,241,159 		JBrowse link
G Ugt2b17 UDP glucuronosyltransferase family 2 member B17 decreases expression ISO bicalutamide results in decreased expression of UGT2B17 mRNA CTD PMID:15638997 NCBI chr14:22,724,399...22,736,148
Ensembl chr14:22,724,070...22,825,444 		JBrowse link
G Upp1 uridine phosphorylase 1 increases expression ISO bicalutamide results in increased expression of UPP1 mRNA CTD PMID:15638997 NCBI chr14:89,314,234...89,334,060
Ensembl chr14:89,314,176...89,334,276 		JBrowse link
G Uxt ubiquitously-expressed, prefoldin-like chaperone affects response to substance ISO UXT protein affects the susceptibility to bicalutamide CTD PMID:19318562 NCBI chr  X:1,275,402...1,287,781
Ensembl chr  X:1,275,612...1,287,512 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] CTD PMID:16317058 NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619 		JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 increases expression ISO bicalutamide results in increased expression of WARS1 mRNA CTD PMID:15638997 NCBI chr 6:132,771,026...132,802,262
Ensembl chr 6:132,771,021...132,802,210 		JBrowse link
G Ythdf3 YTH N(6)-methyladenosine RNA binding protein 3 increases expression ISO bicalutamide results in increased expression of YTHDF3 mRNA CTD PMID:16631469 NCBI chr 2:100,677,388...100,711,365
Ensembl chr 2:100,677,411...100,710,417 		JBrowse link
G Zmat3 zinc finger, matrin type 3 increases expression ISO bicalutamide results in increased expression of ZMAT3 mRNA CTD PMID:15638997 NCBI chr 2:118,715,229...118,746,109
Ensembl chr 2:118,721,334...118,745,766 		JBrowse link
G Zwint ZW10 interacting kinetochore protein decreases expression ISO bicalutamide results in decreased expression of ZWINT mRNA CTD PMID:15638997 NCBI chr20:17,075,781...17,091,715
Ensembl chr20:17,075,771...17,091,766 		JBrowse link
binimetinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [NADP co-treated with binimetinib] results in decreased activity of CYP1A2 protein CTD PMID:33728909 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301 		JBrowse link
cobimetinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bcl2l11 BCL2 like 11 increases expression
multiple interactions		 ISO cobimetinib results in increased expression of BCL2L11 protein; cobimetinib results in increased expression of BCL2L11 protein alternative form
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in increased expression of BCL2L11 protein alternative form]; 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in increased expression of BCL2L11 protein]; [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine co-treated with cobimetinib] results in decreased phosphorylation of BCL2L11 protein alternative form; cobimetinib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased expression of BCL2L11 protein alternative form]		 CTD PMID:22084396 NCBI chr 3:120,726,906...120,764,192
Ensembl chr 3:120,726,906...120,764,192 		JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase multiple interactions
increases response to substance		 ISO 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [BRAF protein mutant form results in increased susceptibility to cobimetinib] CTD PMID:22084396 NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356 		JBrowse link
G Ccnd1 cyclin D1 decreases expression
multiple interactions		 ISO cobimetinib results in decreased expression of CCND1 protein
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in decreased expression of CCND1 protein]		 CTD PMID:22084396 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325 		JBrowse link
G Gpt glutamic--pyruvic transaminase increases secretion EXP cobimetinib results in increased secretion of GPT protein CTD PMID:29655783 NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931 		JBrowse link
G Kras KRAS proto-oncogene, GTPase increases response to substance
multiple interactions		 ISO KRAS protein mutant form results in increased susceptibility to cobimetinib
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [KRAS protein mutant form results in increased susceptibility to cobimetinib]; cobimetinib promotes the reaction [KRAS protein mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine]		 CTD PMID:22084396 NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 decreases phosphorylation ISO cobimetinib results in decreased phosphorylation of MAPK1 protein CTD PMID:22084396 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 decreases phosphorylation ISO cobimetinib results in decreased phosphorylation of MAPK3 protein CTD PMID:22084396 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975 		JBrowse link
G Nras NRAS proto-oncogene, GTPase increases response to substance ISO NRAS protein mutant form results in increased susceptibility to cobimetinib CTD PMID:22084396 NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
increases cleavage		 ISO 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in increased cleavage of PARP1 protein]; cobimetinib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein] CTD PMID:22084396 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716 		JBrowse link
G Rps6 ribosomal protein S6 multiple interactions ISO cobimetinib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased phosphorylation of RPS6 protein] CTD PMID:22084396 NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148
Ensembl chr 5:105,197,857...105,200,148 		JBrowse link
dacomitinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Egfr epidermal growth factor receptor multiple interactions ISO dacomitinib inhibits the reaction [EGFR protein results in increased phosphorylation of EGFR protein] CTD PMID:27491023 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796 		JBrowse link
DAPT term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acta2 actin alpha 2, smooth muscle multiple interactions ISO 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]] CTD PMID:31348943 NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein] CTD PMID:31348943 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258 		JBrowse link
G App amyloid beta precursor protein multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form] CTD PMID:22115781 NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of BAX protein CTD PMID:21209419 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of BCL2 protein CTD PMID:21209419 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374 		JBrowse link
G Bmp6 bone morphogenetic protein 6 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA] CTD PMID:23566955 NCBI chr17:26,955,142...27,112,820
Ensembl chr17:26,955,142...27,112,820 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of and results in increased activity of CASP3 protein CTD PMID:21209419 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of CCND1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA] CTD PMID:19160421 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester co-treated with 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one] inhibits the reaction [polyhexamethyleneguanidine results in decreased expression of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased secretion of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased cleavage of CDH1 protein] CTD PMID:18791180 PMID:31348943 NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395 		JBrowse link
G Cdh2 cadherin 2 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH2 protein] CTD PMID:23876460 NCBI chr18:8,146,971...8,366,037
Ensembl chr18:8,146,971...8,360,684 		JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of CSF1 mRNA] CTD PMID:24223152 NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560 		JBrowse link
G Eno2 enolase 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of ENO2 mRNA] CTD PMID:24929042 NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
Ensembl chr 9:157,285,179...157,294,047 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of FLT1 protein] CTD PMID:21843347 NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905 		JBrowse link
G Foxo3 forkhead box O3 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of FOXO3 protein] CTD PMID:25108166 NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions
decreases expression		 ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HES1 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of HES1 protein		 CTD PMID:19160421 PMID:24223152 PMID:25005833 PMID:25108166 PMID:32041402 NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248 		JBrowse link
G Hey1 hes-related family bHLH transcription factor with YRPW motif 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA] CTD PMID:19160421 NCBI chr 2:95,320,147...95,322,701
Ensembl chr 2:95,320,283...95,322,696 		JBrowse link
G Hey2 hes-related family bHLH transcription factor with YRPW motif 2 multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Niclosamide results in increased expression of HEY2 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HEY2 mRNA]		 CTD PMID:19160421 PMID:32041402 NCBI chr 1:29,191,170...29,201,257
Ensembl chr 1:29,191,192...29,201,531 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of HIF1A protein] CTD PMID:25108166 NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of HMGB1 protein] CTD PMID:21843347 NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237 		JBrowse link
G Il10 interleukin 10 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA] CTD PMID:24223152 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]		 CTD PMID:21843347 PMID:24223152 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726 		JBrowse link
G Il6 interleukin 6 multiple interactions EXP
ISO		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]		 CTD PMID:21843347 PMID:24223152 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807 		JBrowse link
G Itgam integrin subunit alpha M multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of ITGAM protein] CTD PMID:28130038 NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960 		JBrowse link
G Ivl involucrin decreases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL protein CTD PMID:18633435 NCBI chr 2:192,761,171...192,773,346
Ensembl chr 2:192,761,538...192,763,577 		JBrowse link
G Jag1 jagged canonical Notch ligand 1 decreases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 protein CTD PMID:18633435 NCBI chr 3:130,079,361...130,114,781
Ensembl chr 3:130,079,361...130,114,770 		JBrowse link
G Krt1 keratin 1 multiple interactions
decreases expression		 ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT1 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT1 mRNA		 CTD PMID:18633435 PMID:23566955 NCBI chr 7:143,448,318...143,453,544
Ensembl chr 7:143,448,318...143,453,544 		JBrowse link
G Krt10 keratin 10 multiple interactions
decreases expression		 ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT10 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 protein		 CTD PMID:18633435 PMID:23566955 NCBI chr10:87,296,445...87,301,307
Ensembl chr10:87,296,451...87,300,736 		JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of LGR5 mRNA] CTD PMID:32041402 NCBI chr 7:58,447,097...58,587,787
Ensembl chr 7:58,448,277...58,587,787 		JBrowse link
G Map2 microtubule-associated protein 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of MAP2 mRNA] CTD PMID:24929042 NCBI chr 9:73,204,753...73,462,965
Ensembl chr 9:73,319,710...73,462,972 		JBrowse link
G Mdm2 MDM2 proto-oncogene multiple interactions
increases expression		 ISO Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein] CTD PMID:25005833 NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]		 CTD PMID:24223152 NCBI chr 8:128,022,512...128,027,462
Ensembl chr 8:128,022,473...128,026,841 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]		 CTD PMID:24223152 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190 		JBrowse link
G Notch1 notch receptor 1 multiple interactions
decreases expression		 ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of and results in increased activity of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of NOTCH1 protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Oxygen deficiency results in increased expression of NOTCH1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH1 protein modified form		 CTD PMID:18633435 PMID:22039516 PMID:22115781 PMID:24223152 PMID:25108166 PMID:25118938 PMID:28130038 PMID:31348943 NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025 		JBrowse link
G Notch2 notch receptor 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH2 protein CTD PMID:22039516 NCBI chr 2:200,187,184...200,320,403
Ensembl chr 2:200,187,179...200,320,215 		JBrowse link
G Numb NUMB, endocytic adaptor protein increases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of NUMB protein CTD PMID:25005833 NCBI chr 6:107,279,917...107,325,345
Ensembl chr 6:107,279,920...107,325,345 		JBrowse link
G Pml PML nuclear body scaffold multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 NCBI chr 8:63,002,515...63,034,310
Ensembl chr 8:63,004,870...63,034,226 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA] CTD PMID:18791180 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335 		JBrowse link
G Rara retinoic acid receptor, alpha multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 NCBI chr10:86,838,819...86,884,224
Ensembl chr10:86,860,685...86,884,210 		JBrowse link
G Rbpj recombination signal binding protein for immunoglobulin kappa J region multiple interactions
increases expression		 EXP
ISO		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RBPJ mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of RBPJ protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cycloheximide results in decreased expression of RBPJ protein]		 CTD PMID:22302987 PMID:24223152 NCBI chr14:59,657,738...59,865,427
Ensembl chr14:59,658,935...59,735,450 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of RELA protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RELA protein] CTD PMID:24223152 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TGFB1 mRNA] CTD PMID:24223152 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TLR4 mRNA] CTD PMID:24223152 NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF mRNA]		 CTD PMID:24223152 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
Ensembl chr20:5,189,390...5,192,000 		JBrowse link
G Tp53 tumor protein p53 decreases expression
multiple interactions		 ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein
Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein]		 CTD PMID:25005833 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449 		JBrowse link
G Traf6 TNF receptor associated factor 6 multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 mRNA]		 CTD PMID:24223152 NCBI chr 3:91,252,829...91,271,607
Ensembl chr 3:91,252,829...91,271,607 		JBrowse link
G Tubb3 tubulin, beta 3 class III multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of TUBB3 mRNA] CTD PMID:24929042 NCBI chr19:56,220,759...56,229,813
Ensembl chr19:56,220,755...56,229,813 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of VEGFA protein] CTD PMID:21843347 NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681 		JBrowse link
G Vil1 villin 1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of VIL1 mRNA] CTD PMID:32041402 NCBI chr 9:81,689,802...81,717,623
Ensembl chr 9:81,689,802...81,717,621 		JBrowse link
diflubenzuron term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression EXP Diflubenzuron results in increased expression of CYP1A1 protein CTD PMID:8812189 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 affects binding ISO Diflubenzuron binds to CYP1A2 protein CTD PMID:32278787 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression EXP Diflubenzuron results in increased expression of CYP3A23-3A1 protein CTD PMID:8812189 NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO Diflubenzuron results in increased activity of NR1I2 protein CTD PMID:16565514 NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545 		JBrowse link
diflunisal term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Diflunisal results in increased expression of FOS mRNA CTD PMID:12730611 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299 		JBrowse link
G Il1b interleukin 1 beta increases expression EXP Diflunisal results in increased expression of IL1B mRNA CTD PMID:15135310 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726 		JBrowse link
G Il6 interleukin 6 increases expression EXP Diflunisal results in increased expression of IL6 mRNA CTD PMID:15135310 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807 		JBrowse link
G Nos2 nitric oxide synthase 2 increases expression EXP Diflunisal results in increased expression of NOS2 mRNA CTD PMID:15135310 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190 		JBrowse link
G Slc6a8 solute carrier family 6 member 8 increases expression ISO Diflunisal results in increased expression of SLC6A8 mRNA CTD PMID:29901742 NCBI chr  X:157,129,987...157,139,321
Ensembl chr  X:157,129,987...157,139,291 		JBrowse link
G Tnf tumor necrosis factor increases expression EXP Diflunisal results in increased expression of TNF mRNA CTD PMID:15135310 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
Ensembl chr20:5,189,390...5,192,000 		JBrowse link
G Ttr transthyretin affects binding
multiple interactions		 ISO Diflunisal binds to TTR protein mutant form
[Diflunisal binds to TTR protein mutant form] which results in decreased susceptibility to Urea; Diflunisal results in increased stability of [TTR protein binds to TTR protein binds to TTR protein binds to TTR protein]		 CTD PMID:17701470 PMID:27093678 NCBI chr18:15,532,963...15,542,180
Ensembl chr18:15,532,963...15,540,177 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 decreases activity ISO Diflunisal results in decreased activity of UGT1A1 protein CTD PMID:15593333 NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822 		JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 increases glucuronidation ISO UGT1A3 protein results in increased glucuronidation of Diflunisal CTD PMID:15117964 NCBI chr 9:95,285,592...95,302,822
Ensembl chr 9:95,161,157...95,302,822 		JBrowse link
G Ugt1a8 UDP glucuronosyltransferase family 1 member A8 increases glucuronidation ISO UGT1A8 protein results in increased glucuronidation of Diflunisal CTD PMID:15117964 NCBI chr 9:95,221,474...95,302,822
Ensembl chr 9:95,161,157...95,302,822 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 multiple interactions
increases glucuronidation		 ISO Diflunisal inhibits the reaction [UGT2B7 protein results in increased chemical synthesis of aldosterone 18-glucuronide]; Diflunisal inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]
UGT2B7 protein alternative form results in increased glucuronidation of Diflunisal; UGT2B7 protein results in increased glucuronidation of Diflunisal		 CTD PMID:8423545 PMID:8517101 PMID:19740398 NCBI chr14:22,597,103...22,619,968 JBrowse link
enzalutamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aadat aminoadipate aminotransferase decreases expression ISO enzalutamide results in decreased expression of AADAT mRNA CTD PMID:29581250 NCBI chr16:32,832,001...32,868,680
Ensembl chr16:32,832,061...32,868,702 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 decreases expression ISO enzalutamide results in decreased expression of ABCC4 mRNA CTD PMID:29581250 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592 		JBrowse link
G Acsm1 acyl-CoA synthetase medium-chain family member 1 decreases expression ISO enzalutamide results in decreased expression of ACSM1 mRNA CTD PMID:29581250 NCBI chr 1:189,359,374...189,395,277
Ensembl chr 1:189,289,957...189,395,276 		JBrowse link
G Adam10 ADAM metallopeptidase domain 10 affects expression ISO enzalutamide affects the expression of ADAM10 mRNA CTD PMID:30940724 NCBI chr 8:77,107,355...77,237,483
Ensembl chr 8:77,107,536...77,237,483 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 affects expression ISO enzalutamide affects the expression of ADAM17 mRNA CTD PMID:30940724 NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280 		JBrowse link
G Adprm ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent decreases expression ISO enzalutamide results in decreased expression of ADPRM mRNA CTD PMID:29581250 NCBI chr10:53,583,275...53,595,821
Ensembl chr10:53,583,276...53,595,827 		JBrowse link
G Aff3 AF4/FMR2 family, member 3 decreases expression ISO enzalutamide results in decreased expression of AFF3 mRNA CTD PMID:29581250 NCBI chr 9:44,837,979...45,291,964
Ensembl chr 9:44,839,960...45,292,047 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 decreases expression ISO enzalutamide results in decreased expression of ALDH1A3 mRNA CTD PMID:29581250 NCBI chr 1:127,302,920...127,337,828
Ensembl chr 1:127,301,128...127,337,882 		JBrowse link
G Alpk2 alpha-kinase 2 decreases expression ISO enzalutamide results in decreased expression of ALPK2 mRNA CTD PMID:29581250 NCBI chr18:60,960,009...61,072,116
Ensembl chr18:60,960,662...61,057,365 		JBrowse link
G Anxa4 annexin A4 affects expression ISO enzalutamide affects the expression of ANXA4 mRNA CTD PMID:30940724 NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580 		JBrowse link
G Aph1a aph-1 homolog A, gamma secretase subunit affects expression ISO enzalutamide affects the expression of APH1A mRNA CTD PMID:30940724 NCBI chr 2:198,006,247...198,009,837
Ensembl chr 2:198,006,316...198,009,830 		JBrowse link
G Aph1b aph-1 homolog B, gamma secretase subunit affects expression ISO enzalutamide affects the expression of APH1B mRNA CTD PMID:30940724 NCBI chr 8:72,508,008...72,598,921
Ensembl chr 8:72,476,425...72,629,265 		JBrowse link
G App amyloid beta precursor protein affects expression ISO enzalutamide affects the expression of APP mRNA CTD PMID:30940724 NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858 		JBrowse link
G Ar androgen receptor multiple interactions
decreases activity
decreases response to substance
decreases expression		 ISO [enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]; [enzalutamide co-treated with Niclosamide] results in decreased expression of AR protein; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR mRNA; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR mRNA alternative form; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR protein; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR protein alternative form; [nirogacestat results in increased susceptibility to enzalutamide] which results in decreased expression of AR protein; enzalutamide binds to and results in decreased localization of and results in decreased activity of AR protein; enzalutamide inhibits the reaction [Dihydrotestosterone affects the localization of AR protein]; enzalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; enzalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Niclosamide inhibits the reaction [AR protein alternative form results in decreased susceptibility to enzalutamide]
enzalutamide results in decreased activity of AR protein
AR alternative form results in decreased susceptibility to enzalutamide; AR protein alternative form results in decreased susceptibility to enzalutamide; AR protein results in decreased susceptibility to enzalutamide
enzalutamide results in decreased expression of AR protein; enzalutamide results in decreased expression of AR protein alternative form		 CTD PMID:19359544 PMID:24740322 PMID:24759320 PMID:25908785 PMID:25970160 PMID:28757136 PMID:30940724 PMID:32184358 PMID:32805266 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding decreases expression ISO enzalutamide results in decreased expression of AZGP1 mRNA CTD PMID:29581250 NCBI chr12:19,196,565...19,203,094
Ensembl chr12:19,196,611...19,202,647 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions ISO enzalutamide promotes the reaction [Niclosamide results in decreased expression of BIRC5 protein] CTD PMID:25970160 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413 		JBrowse link
G Bmpr1b bone morphogenetic protein receptor type 1B decreases expression ISO enzalutamide results in decreased expression of BMPR1B mRNA CTD PMID:29581250 NCBI chr 2:247,392,195...247,662,026
Ensembl chr 2:247,403,920...247,446,882 		JBrowse link
G Casp3 caspase 3 multiple interactions
decreases expression		 ISO enzalutamide promotes the reaction [NVP-BHG712 results in increased cleavage of CASP3 protein]
enzalutamide results in decreased expression of CASP3 protein		 CTD PMID:32184358 PMID:32805266 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204 		JBrowse link
G Casp8 caspase 8 decreases expression ISO enzalutamide results in decreased expression of CASP8 protein CTD PMID:32805266 NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106 		JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO enzalutamide results in decreased expression of CCNB1 protein CTD PMID:32805266 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221 		JBrowse link
G Cd46 CD46 molecule increases expression ISO enzalutamide results in increased expression of CD46 protein CTD PMID:30185663 NCBI chr13:113,786,525...113,818,741
Ensembl chr13:113,787,349...113,817,995 		JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO [enzalutamide co-treated with NVP-BHG712] results in decreased expression of CDC25C mRNA; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of CDC25C protein CTD PMID:32184358 NCBI chr18:27,528,768...27,550,316
Ensembl chr18:27,528,354...27,550,224 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B affects expression ISO enzalutamide affects the expression of CDKN1B mRNA CTD PMID:30940724 NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha affects expression ISO enzalutamide affects the expression of CEBPA mRNA CTD PMID:30940724 NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164 		JBrowse link
G Crebbp CREB binding protein affects expression ISO enzalutamide affects the expression of CREBBP mRNA CTD PMID:30940724 NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039 		JBrowse link
G Crisp3 cysteine-rich secretory protein 3 decreases expression ISO enzalutamide results in decreased expression of CRISP3 mRNA CTD PMID:29581250 NCBI chr 9:24,047,405...24,088,066
Ensembl chr 9:24,066,303...24,088,064 		JBrowse link
G Crym crystallin, mu multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of CRYM mRNA] CTD PMID:29581250 NCBI chr 1:189,944,895...189,960,069
Ensembl chr 1:189,944,895...189,960,073 		JBrowse link
G Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 decreases expression ISO enzalutamide results in decreased expression of CSGALNACT1 mRNA CTD PMID:29581250 NCBI chr16:22,704,318...23,075,071
Ensembl chr16:22,979,444...23,074,798 		JBrowse link
G Dpp4 dipeptidylpeptidase 4 decreases expression ISO enzalutamide results in decreased expression of DPP4 mRNA CTD PMID:29581250 NCBI chr 3:48,291,055...48,372,672
Ensembl chr 3:48,291,055...48,372,672 		JBrowse link
G Dtx2 deltex E3 ubiquitin ligase 2 affects expression ISO enzalutamide affects the expression of DTX2 mRNA CTD PMID:30940724 NCBI chr12:23,687,958...23,727,594
Ensembl chr12:23,687,966...23,727,564 		JBrowse link
G Dtx3 deltex E3 ubiquitin ligase 3 affects expression ISO enzalutamide affects the expression of DTX3 mRNA CTD PMID:30940724 NCBI chr 7:70,476,737...70,482,852
Ensembl chr 7:70,476,729...70,481,796 		JBrowse link
G Dtx4 deltex E3 ubiquitin ligase 4 affects expression ISO enzalutamide affects the expression of DTX4 mRNA CTD PMID:30940724 NCBI chr 1:228,729,842...228,759,783
Ensembl chr 1:228,732,985...228,755,866 		JBrowse link
G Edem3 ER degradation enhancing alpha-mannosidase like protein 3 decreases expression ISO enzalutamide results in decreased expression of EDEM3 mRNA CTD PMID:29581250 NCBI chr13:69,135,095...69,197,708
Ensembl chr13:69,135,128...69,199,511 		JBrowse link
G Eed embryonic ectoderm development multiple interactions
decreases expression		 ISO [enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]; enzalutamide promotes the reaction [GSK-2816126 results in decreased expression of EED protein]; GSK-2816126 promotes the reaction [enzalutamide results in decreased expression of EED protein] CTD PMID:32805266 NCBI chr 1:154,189,252...154,216,340
Ensembl chr 1:154,189,260...154,216,340 		JBrowse link
G Efcab12 EF-hand calcium binding domain 12 decreases expression ISO enzalutamide results in decreased expression of EFCAB12 mRNA CTD PMID:29581250 NCBI chr 4:147,720,813...147,743,342
Ensembl chr 4:147,721,045...147,742,114 		JBrowse link
G Ell2 elongation factor for RNA polymerase II 2 decreases expression ISO enzalutamide results in decreased expression of ELL2 mRNA CTD PMID:29581250 NCBI chr 2:2,456,189...2,525,590
Ensembl chr 2:2,456,735...2,524,237 		JBrowse link
G Elovl7 ELOVL fatty acid elongase 7 decreases expression ISO enzalutamide results in decreased expression of ELOVL7 mRNA CTD PMID:29581250 NCBI chr 2:40,373,211...40,386,643
Ensembl chr 2:40,373,211...40,386,669 		JBrowse link
G Ep300 E1A binding protein p300 affects expression ISO enzalutamide affects the expression of EP300 mRNA CTD PMID:30940724 NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296 		JBrowse link
G Ephb4 EPH receptor B4 affects response to substance
multiple interactions		 ISO EPHB4 protein affects the susceptibility to enzalutamide
enzalutamide promotes the reaction [EPHB4 protein affects the expression of KLK3 protein]; EPHB4 protein affects the reaction [enzalutamide results in decreased cleavage of PARP1 protein]		 CTD PMID:32184358 NCBI chr12:22,393,338...22,418,332
Ensembl chr12:22,393,330...22,417,980 		JBrowse link
G Epn1 Epsin 1 affects expression ISO enzalutamide affects the expression of EPN1 mRNA CTD PMID:30940724 NCBI chr 1:72,294,153...72,310,217
Ensembl chr 1:72,294,153...72,311,856 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression
multiple interactions		 ISO enzalutamide results in decreased expression of EZH2 protein
[enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]		 CTD PMID:32805266 NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions
decreases expression		 ISO [enzalutamide co-treated with NVP-BHG712] results in decreased expression of FKBP5 mRNA; enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of FKBP5 mRNA]; NVP-BHG712 promotes the reaction [enzalutamide results in decreased expression of FKBP5 mRNA] CTD PMID:32184358 NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020 		JBrowse link
G Foxa1 forkhead box A1 affects expression ISO enzalutamide affects the expression of FOXA1 mRNA CTD PMID:30940724 NCBI chr 6:78,516,579...78,549,669
Ensembl chr 6:78,545,804...78,549,669 		JBrowse link
G Galnt11 polypeptide N-acetylgalactosaminyltransferase 11 affects expression ISO enzalutamide affects the expression of GALNT11 mRNA CTD PMID:30940724 NCBI chr 4:6,297,255...6,330,765
Ensembl chr 4:6,297,258...6,330,765 		JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase affects expression ISO enzalutamide affects the expression of GMDS mRNA CTD PMID:30940724 NCBI chr17:33,408,722...33,938,086
Ensembl chr17:33,408,722...33,938,085 		JBrowse link
G Gnmt glycine N-methyltransferase decreases expression ISO enzalutamide results in decreased expression of GNMT mRNA CTD PMID:29581250 NCBI chr 9:16,565,274...16,568,626
Ensembl chr 9:16,565,225...16,568,627 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 affects expression ISO enzalutamide affects the expression of GOT1 mRNA CTD PMID:30940724 NCBI chr 1:263,246,248...263,269,762
Ensembl chr 1:263,246,248...263,269,762 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 decreases expression ISO enzalutamide results in decreased expression of GREB1 mRNA CTD PMID:29581250 NCBI chr 6:41,932,941...42,002,770
Ensembl chr 6:41,932,244...42,002,819 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 affects expression ISO enzalutamide affects the expression of HES1 mRNA CTD PMID:30940724 NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248 		JBrowse link
G Hnf1b HNF1 homeobox B affects expression ISO enzalutamide affects the expression of HNF1B mRNA CTD PMID:30940724 NCBI chr10:71,159,863...71,218,902
Ensembl chr10:71,159,869...71,218,902 		JBrowse link
G Ift172 intraflagellar transport 172 affects expression ISO enzalutamide affects the expression of IFT172 mRNA CTD PMID:30940724 NCBI chr 6:26,390,686...26,485,459 JBrowse link
G Ift74 intraflagellar transport 74 affects expression ISO enzalutamide affects the expression of IFT74 mRNA CTD PMID:30940724 NCBI chr 5:113,579,065...113,682,485
Ensembl chr 5:113,592,919...113,682,484 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression ISO enzalutamide results in decreased expression of IGF1 mRNA CTD PMID:29581250 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression ISO enzalutamide results in decreased expression of IGF1R mRNA CTD PMID:29581250 NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516 		JBrowse link
G Il6 interleukin 6 multiple interactions
decreases response to substance		 ISO Niclosamide inhibits the reaction [IL6 protein results in decreased susceptibility to enzalutamide] CTD PMID:25970160 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807 		JBrowse link
G Iqgap2 IQ motif containing GTPase activating protein 2 decreases expression ISO enzalutamide results in decreased expression of IQGAP2 mRNA CTD PMID:29581250 NCBI chr 2:26,161,628...26,439,067
Ensembl chr 2:26,167,199...26,438,790 		JBrowse link
G Itch itchy E3 ubiquitin protein ligase affects expression ISO enzalutamide affects the expression of ITCH mRNA CTD PMID:30940724 NCBI chr 3:150,660,665...150,752,016
Ensembl chr 3:150,686,638...150,749,827 		JBrowse link
G Itgb1bp1 integrin subunit beta 1 binding protein 1 affects expression ISO enzalutamide affects the expression of ITGB1BP1 mRNA CTD PMID:30940724 NCBI chr 6:43,348,927...43,363,633
Ensembl chr 6:43,348,958...43,363,335 		JBrowse link
G Jag1 jagged canonical Notch ligand 1 affects expression ISO enzalutamide affects the expression of JAG1 mRNA CTD PMID:30940724 NCBI chr 3:130,079,361...130,114,781
Ensembl chr 3:130,079,361...130,114,770 		JBrowse link
G Jag2 jagged canonical Notch ligand 2 affects expression ISO enzalutamide affects the expression of JAG2 mRNA CTD PMID:30940724 NCBI chr 6:137,711,144...137,733,331
Ensembl chr 6:137,711,155...137,733,026 		JBrowse link
G Kat2b lysine acetyltransferase 2B affects expression ISO enzalutamide affects the expression of KAT2B mRNA CTD PMID:30940724 NCBI chr 9:4,440,982...4,492,949 JBrowse link
G Kdm1a lysine demethylase 1A multiple interactions ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of CRYM mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of KLK3 protein]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of LCP1 mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MAP2 mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MYO1B mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of SLC22A3 mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of TMCC3 mRNA] CTD PMID:29581250 NCBI chr 5:154,909,003...154,965,171
Ensembl chr 5:154,909,003...154,965,171 		JBrowse link
G Kif5c kinesin family member 5C decreases expression ISO enzalutamide results in decreased expression of KIF5C mRNA CTD PMID:29581250 NCBI chr 3:35,014,157...35,257,417
Ensembl chr 3:35,014,538...35,257,407 		JBrowse link
G Krt19 keratin 19 affects expression ISO enzalutamide affects the expression of KRT19 mRNA CTD PMID:30940724 NCBI chr10:88,055,843...88,060,560
Ensembl chr10:88,055,841...88,060,561 		JBrowse link
G Lck LCK proto-oncogene, Src family tyrosine kinase decreases expression ISO enzalutamide results in decreased expression of LCK mRNA CTD PMID:29581250 NCBI chr 5:147,750,976...147,779,627
Ensembl chr 5:147,750,973...147,761,983 		JBrowse link
G Lcp1 lymphocyte cytosolic protein 1 multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of LCP1 mRNA] CTD PMID:29581250 NCBI chr15:57,170,566...57,277,811
Ensembl chr15:57,221,292...57,277,811 		JBrowse link
G LOC498222 similar to specifically androgen-regulated protein decreases expression ISO enzalutamide results in decreased expression of C1ORF116 mRNA CTD PMID:29581250 NCBI chr13:47,452,436...47,467,432
Ensembl chr13:47,454,591...47,467,432 		JBrowse link
G Maf MAF bZIP transcription factor decreases expression ISO enzalutamide results in decreased expression of MAF mRNA CTD PMID:29581250 NCBI chr19:48,179,826...48,200,995
Ensembl chr19:48,194,804...48,196,748 		JBrowse link
G Maml1 mastermind-like transcriptional coactivator 1 affects expression ISO enzalutamide affects the expression of MAML1 mRNA CTD PMID:30940724 NCBI chr10:35,765,196...35,801,375
Ensembl chr10:35,765,719...35,800,120 		JBrowse link
G Maml3 mastermind-like transcriptional coactivator 3 affects expression ISO enzalutamide affects the expression of MAML3 mRNA CTD PMID:30940724 NCBI chr 2:140,734,138...141,276,886 JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions ISO [enzalutamide co-treated with GSK-2816126] results in increased expression of MAP1LC3B protein modified form CTD PMID:32805266 NCBI chr19:53,635,449...53,643,970
Ensembl chr19:53,629,779...53,646,058 		JBrowse link
G Map2 microtubule-associated protein 2 multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MAP2 mRNA] CTD PMID:29581250 NCBI chr 9:73,204,753...73,462,965
Ensembl chr 9:73,319,710...73,462,972 		JBrowse link
G Mdk midkine affects expression ISO enzalutamide affects the expression of MDK mRNA CTD PMID:30940724 NCBI chr 3:80,841,003...80,843,895
Ensembl chr 3:80,841,005...80,842,916 		JBrowse link
G Mib1 MIB E3 ubiquitin protein ligase 1 affects expression ISO enzalutamide affects the expression of MIB1 mRNA CTD PMID:30940724 NCBI chr18:1,970,914...2,094,920
Ensembl chr18:1,970,914...2,094,920 		JBrowse link
G Mib2 MIB E3 ubiquitin protein ligase 2 affects expression ISO enzalutamide affects the expression of MIB2 mRNA CTD PMID:30940724 NCBI chr 5:173,082,943...173,099,353
Ensembl chr 5:173,082,943...173,098,816 		JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions ISO enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MKI67 protein] CTD PMID:32184358 NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454 		JBrowse link
G Mpc2 mitochondrial pyruvate carrier 2 decreases expression ISO enzalutamide results in decreased expression of BRP44 mRNA CTD PMID:29581250 NCBI chr13:83,680,527...83,700,491
Ensembl chr13:83,681,322...83,700,213 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor decreases expression
multiple interactions
affects expression		 ISO enzalutamide results in decreased expression of MYC protein
[enzalutamide co-treated with NVP-BHG712] results in decreased expression of MYC protein; enzalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; enzalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of MYC mRNA]; enzalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of MYC protein]; enzalutamide promotes the reaction [Niclosamide results in decreased expression of MYC protein]; enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MYC protein]
enzalutamide affects the expression of MYC mRNA		 CTD PMID:24759320 PMID:25970160 PMID:30940724 PMID:32184358 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240 		JBrowse link
G Myo1b myosin Ib multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MYO1B mRNA] CTD PMID:29581250 NCBI chr 9:54,706,005...54,766,054
Ensembl chr 9:54,558,202...54,766,054 		JBrowse link
G Ncstn nicastrin affects expression ISO enzalutamide affects the expression of NCSTN mRNA CTD PMID:30940724 NCBI chr13:90,451,046...90,467,256
Ensembl chr13:90,451,044...90,467,256 		JBrowse link
G Neurl1b neuralized E3 ubiquitin protein ligase 1B affects expression ISO enzalutamide affects the expression of NEURL1B mRNA CTD PMID:30940724 NCBI chr10:17,048,251...17,075,139
Ensembl chr10:17,048,251...17,075,139 		JBrowse link
G Nkap NFKB activating protein affects expression ISO enzalutamide affects the expression of NKAP mRNA CTD PMID:30940724 NCBI chr  X:123,751,196...123,770,595
Ensembl chr  X:123,751,089...123,770,595 		JBrowse link
G Nkx3-1 NK3 homeobox 1 decreases expression
multiple interactions		 ISO enzalutamide results in decreased expression of NKX3-1 mRNA
enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of NKX3-1 mRNA]; NVP-BHG712 promotes the reaction [enzalutamide results in decreased expression of NKX3-1 mRNA]		 CTD PMID:29581250 PMID:32184358 NCBI chr15:51,065,316...51,067,908
Ensembl chr15:51,065,316...51,068,421 		JBrowse link
G Nle1 notchless homolog 1 affects expression ISO enzalutamide affects the expression of NLE1 mRNA CTD PMID:30940724 NCBI chr10:70,250,959...70,261,880
Ensembl chr10:70,250,959...70,259,553 		JBrowse link
G Notch1 notch receptor 1 affects response to substance
affects expression
multiple interactions		 ISO NOTCH1 protein affects the susceptibility to enzalutamide
enzalutamide affects the expression of NOTCH1 mRNA
[NOTCH1 protein affects the susceptibility to enzalutamide] which affects the cleavage of PARP1 protein		 CTD PMID:30940724 NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025 		JBrowse link
G Notch2 notch receptor 2 affects expression ISO enzalutamide affects the expression of NOTCH2 mRNA CTD PMID:30940724 NCBI chr 2:200,187,184...200,320,403
Ensembl chr 2:200,187,179...200,320,215 		JBrowse link
G Notch3 notch receptor 3 affects expression ISO enzalutamide affects the expression of NOTCH3 mRNA CTD PMID:30940724 NCBI chr 7:14,138,495...14,189,688
Ensembl chr 7:14,138,495...14,189,688 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 decreases cleavage
multiple interactions		 ISO enzalutamide results in decreased cleavage of PARP1 protein
[enzalutamide co-treated with GSK-2816126] results in increased cleavage of PARP1 protein; [nirogacestat results in increased susceptibility to enzalutamide] which results in increased cleavage of PARP1 protein; [NOTCH1 protein affects the susceptibility to enzalutamide] which affects the cleavage of PARP1 protein; enzalutamide promotes the reaction [NVP-BHG712 results in increased cleavage of PARP1 protein]; EPHB4 protein affects the reaction [enzalutamide results in decreased cleavage of PARP1 protein]		 CTD PMID:30940724 PMID:32184358 PMID:32805266 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716 		JBrowse link
G Perp p53 apoptosis effector related to PMP22 affects expression ISO enzalutamide affects the expression of PERP mRNA CTD PMID:30940724 NCBI chr 1:14,224,392...14,236,838
Ensembl chr 1:14,224,393...14,236,846 		JBrowse link
G Pla2g5 phospholipase A2, group V decreases expression ISO enzalutamide results in decreased expression of PLA2G5 mRNA CTD PMID:29581250 NCBI chr 5:157,247,601...157,268,968
Ensembl chr 5:157,247,781...157,268,903 		JBrowse link
G Plk1 polo-like kinase 1 multiple interactions ISO [enzalutamide co-treated with NVP-BHG712] results in decreased expression of PLK1 mRNA; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of PLK1 protein; enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of PLK1 mRNA] CTD PMID:32184358 NCBI chr 1:192,115,990...192,125,969
Ensembl chr 1:192,115,966...192,125,989 		JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 decreases expression ISO enzalutamide results in decreased expression of PLOD2 mRNA CTD PMID:29581250 NCBI chr 8:99,977,334...100,059,736
Ensembl chr 8:99,977,334...100,059,736 		JBrowse link
G Pofut1 protein O-fucosyltransferase 1 affects expression ISO enzalutamide affects the expression of POFUT1 mRNA CTD PMID:30940724 NCBI chr 3:148,722,864...148,749,743
Ensembl chr 3:148,722,955...148,747,208 		JBrowse link
G Psen1 presenilin 1 affects expression ISO enzalutamide affects the expression of PSEN1 mRNA CTD PMID:30940724 NCBI chr 6:107,169,514...107,221,000
Ensembl chr 6:107,169,528...107,216,798 		JBrowse link
G Psen2 presenilin 2 affects expression ISO enzalutamide affects the expression of PSEN2 mRNA CTD PMID:30940724 NCBI chr13:98,513,600...98,539,347
Ensembl chr13:98,513,570...98,530,724 		JBrowse link
G Psenen presenilin enhancer gamma secretase subunit affects expression ISO enzalutamide affects the expression of PSENEN mRNA CTD PMID:30940724 NCBI chr 1:89,016,093...89,017,449
Ensembl chr 1:89,016,096...89,017,290 		JBrowse link
G Ptger4 prostaglandin E receptor 4 decreases expression ISO enzalutamide results in decreased expression of PTGER4 mRNA CTD PMID:29581250 NCBI chr 2:54,951,625...54,966,470
Ensembl chr 2:54,952,821...54,963,448 		JBrowse link
G Rbm15 RNA binding motif protein 15 affects expression ISO enzalutamide affects the expression of RBM15 mRNA CTD PMID:30940724 NCBI chr 2:210,079,678...210,090,200
Ensembl chr 2:210,081,770...210,088,949 		JBrowse link
G Rbpj recombination signal binding protein for immunoglobulin kappa J region affects expression ISO enzalutamide affects the expression of RBPJ mRNA CTD PMID:30940724 NCBI chr14:59,657,738...59,865,427
Ensembl chr14:59,658,935...59,735,450 		JBrowse link
G Rgs2 regulator of G-protein signaling 2 decreases expression ISO enzalutamide results in decreased expression of RGS2 mRNA CTD PMID:29581250 NCBI chr13:60,846,458...60,849,061
Ensembl chr13:60,846,308...60,849,094 		JBrowse link
G Rhou ras homolog family member U decreases expression ISO enzalutamide results in decreased expression of RHOU mRNA CTD PMID:29581250 NCBI chr19:56,431,787...56,443,896
Ensembl chr19:56,435,577...56,441,733 		JBrowse link
G Rps19 ribosomal protein S19 affects expression ISO enzalutamide affects the expression of RPS19 mRNA CTD PMID:30940724 NCBI chr 1:81,750,873...81,756,629
Ensembl chr 1:81,750,928...81,756,627 		JBrowse link
G Rps27a ribosomal protein S27a affects expression ISO enzalutamide affects the expression of RPS27A mRNA CTD PMID:30940724 NCBI chr14:113,966,163...113,968,440
Ensembl chr14:113,966,611...113,968,268
Ensembl chr 5:113,966,611...113,968,268 		JBrowse link
G S1pr3 sphingosine-1-phosphate receptor 3 affects expression ISO enzalutamide affects the expression of S1PR3 mRNA CTD PMID:30940724 NCBI chr17:13,799,383...13,812,877
Ensembl chr17:13,799,383...13,812,704 		JBrowse link
G Sel1l SEL1L adaptor subunit of ERAD E3 ubiquitin ligase affects expression ISO enzalutamide affects the expression of SEL1L mRNA CTD PMID:30940724 NCBI chr 6:115,572,683...115,616,904
Ensembl chr 6:115,572,649...115,616,859 		JBrowse link
G Selenop selenoprotein P decreases expression ISO enzalutamide results in decreased expression of SELENOP mRNA CTD PMID:29581250 NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858 		JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of SLC22A3 mRNA] CTD PMID:29581250 NCBI chr 1:48,433,079...48,521,261
Ensembl chr 1:48,433,079...48,521,256 		JBrowse link
G Snw1 SNW domain containing 1 affects expression ISO enzalutamide affects the expression of SNW1 mRNA CTD PMID:30940724 NCBI chr 6:111,483,698...111,507,782
Ensembl chr 6:111,483,703...111,507,782 		JBrowse link
G Socs2 suppressor of cytokine signaling 2 decreases expression ISO enzalutamide results in decreased expression of SOCS2 mRNA CTD PMID:29581250 NCBI chr 7:36,495,496...36,500,878
Ensembl chr 7:36,495,480...36,499,784 		JBrowse link
G Sox9 SRY-box transcription factor 9 affects expression ISO enzalutamide affects the expression of SOX9 mRNA CTD PMID:30940724 NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379 		JBrowse link
G Spen spen family transcriptional repressor affects expression ISO enzalutamide affects the expression of SPEN mRNA CTD PMID:30940724 NCBI chr 5:160,015,573...160,070,915
Ensembl chr 5:160,015,454...160,070,965 		JBrowse link
G Spock1 sparc/osteonectin, cwcv and kazal like domains proteoglycan 1 decreases expression ISO enzalutamide results in decreased expression of SPOCK1 mRNA CTD PMID:29581250 NCBI chr17:7,675,531...7,797,863
Ensembl chr17:7,675,531...7,797,863 		JBrowse link
G St6galnac1 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 decreases expression ISO enzalutamide results in decreased expression of ST6GALNAC1 mRNA CTD PMID:29581250 NCBI chr10:105,713,305...105,723,700
Ensembl chr10:105,713,317...105,723,700 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
decreases response to substance		 ISO enzalutamide promotes the reaction [Niclosamide results in decreased phosphorylation of and results in decreased activity of STAT3 protein]; Niclosamide inhibits the reaction [STAT3 protein results in decreased susceptibility to enzalutamide] CTD PMID:25970160 NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233 		JBrowse link
G Susd5 sushi domain containing 5 affects expression ISO enzalutamide affects the expression of SUSD5 mRNA CTD PMID:30940724 NCBI chr 8:122,331,489...122,370,684
Ensembl chr 8:122,331,583...122,368,368 		JBrowse link
G Suz12 SUZ12 polycomb repressive complex 2 subunit multiple interactions
decreases expression		 ISO [enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]; enzalutamide promotes the reaction [GSK-2816126 results in decreased expression of SUZ12 protein]; GSK-2816126 promotes the reaction [enzalutamide results in decreased expression of SUZ12 protein] CTD PMID:32805266 NCBI chr10:67,325,101...67,371,588
Ensembl chr10:67,325,347...67,369,668 		JBrowse link
G Tenm1 teneurin transmembrane protein 1 decreases expression ISO enzalutamide results in decreased expression of TENM1 mRNA CTD PMID:29581250 NCBI chr  X:129,034,755...129,336,023
NCBI chr  X:128,923,951...128,951,520 		JBrowse link
G Tmcc3 transmembrane and coiled-coil domain family 3 decreases expression
multiple interactions		 ISO enzalutamide results in decreased expression of TMCC3 mRNA
KDM1A protein promotes the reaction [enzalutamide results in decreased expression of TMCC3 mRNA]		 CTD PMID:29581250 NCBI chr 7:35,266,953...35,543,770
Ensembl chr 7:35,309,265...35,543,759 		JBrowse link
G Tmprss2 transmembrane serine protease 2 decreases expression ISO enzalutamide results in decreased expression of TMPRSS2 mRNA CTD PMID:29581250 NCBI chr11:38,063,914...38,103,406
Ensembl chr11:38,063,915...38,103,290 		JBrowse link
G Tpd52 tumor protein D52 decreases expression ISO enzalutamide results in decreased expression of TPD52 mRNA CTD PMID:29581250 NCBI chr 2:94,959,732...95,041,277
Ensembl chr 2:95,008,311...95,040,514 		JBrowse link
G Trpm8 transient receptor potential cation channel, subfamily M, member 8 decreases expression ISO enzalutamide results in decreased expression of TRPM8 mRNA CTD PMID:29581250 NCBI chr 9:95,393,370...95,484,528
Ensembl chr 9:95,398,237...95,482,890 		JBrowse link
G Uba52 ubiquitin A-52 residue ribosomal protein fusion product 1 affects expression ISO enzalutamide affects the expression of UBA52 mRNA CTD PMID:30940724 NCBI chr16:20,668,925...20,671,127
Ensembl chr16:20,668,971...20,671,127 		JBrowse link
G Ubb ubiquitin B affects expression ISO enzalutamide affects the expression of UBB mRNA CTD PMID:30940724 NCBI chr10:48,880,231...48,881,896
Ensembl chr10:48,881,049...48,881,881 		JBrowse link
G Ubc ubiquitin C affects expression ISO enzalutamide affects the expression of UBC mRNA CTD PMID:30940724 NCBI chr12:36,638,457...36,642,734
Ensembl chr12:36,638,457...36,642,734 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C multiple interactions ISO [enzalutamide co-treated with NVP-BHG712] results in decreased expression of UBE2C mRNA CTD PMID:32184358 NCBI chr 3:161,236,971...161,239,371
Ensembl chr 3:161,236,898...161,241,159 		JBrowse link
G Wdr12 WD repeat domain 12 affects expression ISO enzalutamide affects the expression of WDR12 mRNA CTD PMID:30940724 NCBI chr 9:66,851,499...66,878,534
Ensembl chr 9:66,851,940...66,877,972 		JBrowse link
G Wwtr1 WW domain containing transcription regulator 1 decreases expression ISO enzalutamide results in decreased expression of WWTR1 mRNA CTD PMID:29581250 NCBI chr 2:147,577,149...147,693,033
Ensembl chr 2:147,577,089...147,693,082 		JBrowse link
epoxiconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aass aminoadipate-semialdehyde synthase decreases expression ISO epoxiconazole results in decreased expression of AASS mRNA CTD PMID:22334560 NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB11 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB11 mRNA CTD PMID:29038839 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of ABCB1A mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB1A mRNA		 CTD PMID:25182419 PMID:29038839 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515 		JBrowse link
G Abcb1b ATP-binding cassette, subfamily B (MDR/TAP), member 1B increases expression EXP epoxiconazole results in increased expression of ABCB1B mRNA CTD PMID:25182419 NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of ABCC2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC2 mRNA		 CTD PMID:29038839 NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases expression
multiple interactions		 ISO
EXP		 epoxiconazole results in increased expression of ABCC3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC3 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCC3 mRNA		 CTD PMID:22334560 PMID:29038839 NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 increases expression ISO epoxiconazole results in increased expression of ABCC4 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592 		JBrowse link
G Abhd4 abhydrolase domain containing 4, N-acyl phospholipase B increases expression ISO epoxiconazole results in increased expression of ABHD4 mRNA CTD PMID:22334560 NCBI chr15:32,888,233...32,906,861
Ensembl chr15:32,894,938...32,906,850 		JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA CTD PMID:29038839 NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388
Ensembl chr 3:10,041,826...10,144,388 		JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 decreases expression ISO epoxiconazole results in decreased expression of ACAA2 mRNA CTD PMID:22334560 NCBI chr18:70,733,872...70,762,395
Ensembl chr18:70,733,872...70,762,395 		JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 increases expression EXP epoxiconazole results in increased expression of ACAD9 mRNA CTD PMID:29038839 NCBI chr 2:122,782,051...122,806,166
Ensembl chr 2:122,782,060...122,805,768 		JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 decreases expression ISO epoxiconazole results in decreased expression of ACAT1 mRNA CTD PMID:22334560 NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ACAT2 mRNA CTD PMID:29038839 NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653 		JBrowse link
G Acly ATP citrate lyase increases expression EXP epoxiconazole results in increased expression of ACLY mRNA CTD PMID:29038839 NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845 		JBrowse link
G Aco1 aconitase 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA CTD PMID:29038839 NCBI chr 5:56,425,076...56,481,218
Ensembl chr 5:56,425,024...56,481,218 		JBrowse link
G Acot3 acyl-CoA thioesterase 3 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT3 mRNA CTD PMID:29038839 NCBI chr 6:107,531,508...107,537,446
Ensembl chr 6:107,531,528...107,536,789 		JBrowse link
G Acot9 acyl-CoA thioesterase 9 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT9 mRNA CTD PMID:29038839 NCBI chr  X:43,543,069...43,592,200
Ensembl chr  X:43,543,070...43,592,200 		JBrowse link
G Acp2 acid phosphatase 2, lysosomal increases expression ISO epoxiconazole results in increased expression of ACP2 mRNA CTD PMID:22334560 NCBI chr 3:80,020,346...80,030,365
Ensembl chr 3:80,021,440...80,030,363 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression ISO epoxiconazole results in decreased expression of ACSL1 mRNA CTD PMID:22334560 NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246 		JBrowse link
G Actn1 actinin, alpha 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA CTD PMID:25607892 NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555 		JBrowse link
G Adam11 ADAM metallopeptidase domain 11 increases expression ISO epoxiconazole results in increased expression of ADAM11 mRNA CTD PMID:22334560 NCBI chr10:90,731,260...90,749,221
Ensembl chr10:90,731,148...90,749,217 		JBrowse link
G Adh1 alcohol dehydrogenase 1 (class I) decreases expression EXP epoxiconazole results in decreased expression of ADH1 mRNA CTD PMID:29038839 NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857 		JBrowse link
G Adssl1 adenylosuccinate synthase like 1 increases expression ISO epoxiconazole results in increased expression of ADSSL1 mRNA CTD PMID:22334560 NCBI chr 6:137,184,818...137,206,694
Ensembl chr 6:137,184,820...137,206,693 		JBrowse link
G Ahctf1 AT hook containing transcription factor 1 decreases expression ISO epoxiconazole results in decreased expression of AHCTF1 mRNA CTD PMID:22334560 NCBI chr13:98,023,528...98,079,138
Ensembl chr13:98,023,430...98,078,946 		JBrowse link
G Ahr aryl hydrocarbon receptor increases expression ISO
EXP		 epoxiconazole results in increased expression of AHR mRNA CTD PMID:22334560 PMID:25182419 PMID:29038839 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464 		JBrowse link
G Ahsg alpha-2-HS-glycoprotein decreases expression ISO epoxiconazole results in decreased expression of AHSG mRNA CTD PMID:22334560 NCBI chr11:81,711,269...81,717,594 JBrowse link
G Akap1 A-kinase anchoring protein 1 decreases expression ISO epoxiconazole results in decreased expression of AKAP1 mRNA CTD PMID:22334560 NCBI chr10:76,151,013...76,183,987
Ensembl chr10:76,151,038...76,166,276 		JBrowse link
G Akap13 A-kinase anchoring protein 13 decreases expression ISO epoxiconazole results in decreased expression of AKAP13 mRNA CTD PMID:22334560 NCBI chr 1:137,089,558...137,315,272
Ensembl chr 1:137,014,272...137,315,272 		JBrowse link
G Akap9 A-kinase anchoring protein 9 decreases expression ISO epoxiconazole results in decreased expression of AKAP9 mRNA CTD PMID:22334560 NCBI chr 4:27,195,346...27,331,582
Ensembl chr 4:27,195,346...27,331,582 		JBrowse link
G Akr1b7 aldo-keto reductase family 1, member B7 increases expression ISO epoxiconazole results in increased expression of AKR1B7 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 4:61,850,256...61,879,733
Ensembl chr 4:61,850,348...61,862,526 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of ALDH1A1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ALDH1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ALDH1A1 mRNA		 CTD PMID:25182419 PMID:29038839 NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330 		JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 decreases expression ISO epoxiconazole results in decreased expression of ALS2 mRNA CTD PMID:22334560 NCBI chr 9:65,961,361...66,034,396
Ensembl chr 9:65,961,346...66,033,871 		JBrowse link
G Anxa10 annexin A10 increases expression ISO epoxiconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr16:29,674,699...29,741,521
Ensembl chr16:29,674,793...29,741,465 		JBrowse link
G Anxa7 annexin A7 increases expression ISO epoxiconazole results in increased expression of ANXA7 mRNA CTD PMID:22334560 NCBI chr15:4,254,470...4,281,296
Ensembl chr15:4,254,499...4,281,287 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of APEX1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of APEX1 mRNA CTD PMID:29038839 NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082 		JBrowse link
G Apoe apolipoprotein E increases expression EXP epoxiconazole results in increased expression of APOE mRNA CTD PMID:28454766 NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057 		JBrowse link
G Apof apolipoprotein F multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of APOF mRNA CTD PMID:29038839 NCBI chr 7:2,689,501...2,690,938
Ensembl chr 7:2,689,501...2,690,936 		JBrowse link
G Ar androgen receptor multiple interactions ISO epoxiconazole inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026 		JBrowse link
G Arg1 arginase 1 decreases expression ISO epoxiconazole results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863 		JBrowse link
G Arl5a ADP-ribosylation factor like GTPase 5A decreases expression ISO epoxiconazole results in decreased expression of ARL5A mRNA CTD PMID:22334560 NCBI chr 3:37,922,544...37,947,434
Ensembl chr 3:37,924,793...37,947,283 		JBrowse link
G Arpp19 cAMP-regulated phosphoprotein 19 increases expression ISO epoxiconazole results in increased expression of ARPP19 mRNA CTD PMID:22334560 NCBI chr 8:81,949,577...81,972,054
Ensembl chr 8:81,949,877...81,968,589 		JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 increases expression ISO epoxiconazole results in increased expression of ASAH1 mRNA CTD PMID:22334560 NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ASNS mRNA CTD PMID:29038839 NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163 		JBrowse link
G Atf5 activating transcription factor 5 decreases expression ISO epoxiconazole results in decreased expression of ATF5 mRNA CTD PMID:22334560 NCBI chr 1:100,807,821...100,812,410
Ensembl chr 1:100,808,241...100,810,522 		JBrowse link
G Atf6 activating transcription factor 6 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA CTD PMID:29038839 NCBI chr13:89,053,457...89,242,531
Ensembl chr13:89,055,983...89,242,443 		JBrowse link
G Atg16l2 autophagy related 16-like 2 increases expression ISO epoxiconazole results in increased expression of ATG16L2 mRNA CTD PMID:22334560 NCBI chr 1:166,401,271...166,415,078
Ensembl chr 1:166,401,271...166,413,564 		JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
increases expression		 EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATM mRNA
epoxiconazole results in increased expression of ATM mRNA		 CTD PMID:29038839 NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045 		JBrowse link
G Atp6v0e1 ATPase H+ transporting V0 subunit e1 increases expression ISO epoxiconazole results in increased expression of ATP6V0E mRNA CTD PMID:22334560 NCBI chr10:16,769,857...16,792,930
Ensembl chr10:16,769,666...16,792,909 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions
increases expression		 EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATP8B1 mRNA
epoxiconazole results in increased expression of ATP8B1 mRNA		 CTD PMID:29038839 NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354 		JBrowse link
G Atxn7l3b ataxin 7-like 3B decreases expression ISO epoxiconazole results in decreased expression of ATXN7L3B mRNA CTD PMID:22334560 NCBI chr 7:55,600,879...55,604,403
Ensembl chr 7:55,600,889...55,604,403 		JBrowse link
G Bace1 beta-secretase 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361 		JBrowse link
G Bace2 beta-secretase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 NCBI chr11:37,798,397...37,880,624
Ensembl chr11:37,798,370...37,880,821 		JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210 		JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 decreases expression ISO epoxiconazole results in decreased expression of BHMT2 mRNA CTD PMID:22334560 NCBI chr 2:23,272,320...23,289,266
Ensembl chr 2:23,272,328...23,289,266 		JBrowse link
G Bid BH3 interacting domain death agonist decreases expression ISO epoxiconazole results in decreased expression of BID mRNA CTD PMID:22334560 NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203 		JBrowse link
G Bsn bassoon (presynaptic cytomatrix protein) multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA CTD PMID:25607892 NCBI chr 8:116,873,721...116,965,396
Ensembl chr 8:116,873,721...116,965,396 		JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 decreases expression ISO epoxiconazole results in decreased expression of C2CD2 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr11:38,354,746...38,420,133
Ensembl chr11:38,357,424...38,420,119 		JBrowse link
G C4b complement C4B (Chido blood group) decreases expression ISO epoxiconazole results in decreased expression of C4B mRNA CTD PMID:22334560 NCBI chr20:4,302,344...4,316,752
Ensembl chr20:4,302,344...4,316,715 		JBrowse link
G Cacna1a calcium voltage-gated channel subunit alpha1 A multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA CTD PMID:25607892 NCBI chr19:25,453,236...25,749,550
Ensembl chr19:25,526,751...25,749,550 		JBrowse link
G Cacna1b calcium voltage-gated channel subunit alpha1 B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA CTD PMID:25607892 NCBI chr 3:1,740,026...1,924,959
Ensembl chr 3:1,740,024...1,924,827 		JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA CTD PMID:25607892 NCBI chr 4:150,635,808...151,270,790
Ensembl chr 4:150,641,066...150,829,913 		JBrowse link
G Cacna1d calcium voltage-gated channel subunit alpha1 D multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA CTD PMID:25607892 NCBI chr16:6,110,294...6,405,022
Ensembl chr16:6,112,150...6,405,117 		JBrowse link
G Cacna1g calcium voltage-gated channel subunit alpha1 G multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA CTD PMID:25607892 NCBI chr10:82,129,071...82,197,828
Ensembl chr10:82,129,506...82,197,848 		JBrowse link
G Cacna1i calcium voltage-gated channel subunit alpha1 I multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA CTD PMID:25607892 NCBI chr 7:121,521,787...121,619,300
Ensembl chr 7:121,511,097...121,619,283 		JBrowse link
G Cacna2d3 calcium voltage-gated channel auxiliary subunit alpha2delta 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA CTD PMID:25607892 NCBI chr16:4,871,348...5,795,825
Ensembl chr16:4,871,650...5,795,825 		JBrowse link
G Cacnb1 calcium voltage-gated channel auxiliary subunit beta 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA CTD PMID:25607892 NCBI chr10:85,954,138...85,974,764
Ensembl chr10:85,954,138...85,974,651 		JBrowse link
G Cacnb3 calcium voltage-gated channel auxiliary subunit beta 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA CTD PMID:25607892 NCBI chr 7:140,311,120...140,324,902
Ensembl chr 7:140,315,368...140,324,902 		JBrowse link
G Cacng2 calcium voltage-gated channel auxiliary subunit gamma 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA CTD PMID:25607892 NCBI chr 7:119,228,112...119,353,332
Ensembl chr 7:119,228,102...119,352,605 		JBrowse link
G Cacng6 calcium voltage-gated channel auxiliary subunit gamma 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA CTD PMID:25607892 NCBI chr 1:64,307,684...64,322,124
Ensembl chr 1:64,305,438...64,321,241 		JBrowse link
G Cacng7 calcium voltage-gated channel auxiliary subunit gamma 7 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA CTD PMID:25607892 NCBI chr 1:64,374,547...64,405,380
Ensembl chr 1:64,374,603...64,405,149 		JBrowse link
G Cadm1 cell adhesion molecule 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA CTD PMID:25607892 NCBI chr 8:51,858,906...52,200,591
Ensembl chr 8:52,127,399...52,189,722 		JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 NCBI chr14:86,208,876...86,297,727
Ensembl chr14:86,208,901...86,297,652 		JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA CTD PMID:25607892 NCBI chr15:3,936,721...3,995,740
Ensembl chr15:3,936,786...3,995,915
Ensembl chr15:3,936,786...3,995,915 		JBrowse link
G Capns1 calpain, small subunit 1 increases expression ISO epoxiconazole results in increased expression of CAPNS1 mRNA CTD PMID:22334560 NCBI chr 1:91,058,528...91,064,880
Ensembl chr 1:88,652,446...88,657,845
Ensembl chr 1:88,652,446...88,657,845 		JBrowse link
G Cars cysteinyl-tRNA synthetase decreases expression ISO epoxiconazole results in decreased expression of CARS mRNA CTD PMID:22334560 NCBI chr 1:216,759,367...216,801,652
Ensembl chr 1:216,759,366...216,801,656 		JBrowse link
G Casp7 caspase 7 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CASP7 mRNA CTD PMID:29038839 NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774 		JBrowse link
G Cd36 CD36 molecule increases expression
multiple interactions		 ISO
EXP		 epoxiconazole results in increased expression of CD36 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CD36 mRNA		 CTD PMID:22334560 PMID:29038839 NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749 		JBrowse link
G Cd44 CD44 molecule (Indian blood group) multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA CTD PMID:25607892 NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658 		JBrowse link
G Cd81 Cd81 molecule multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA CTD PMID:25607892 NCBI chr 1:216,237,663...216,253,460
Ensembl chr 1:216,237,697...216,253,311 		JBrowse link
G Cdc34 cell division cycle 34, ubiqiutin conjugating enzyme increases expression ISO epoxiconazole results in increased expression of CDC34 mRNA CTD PMID:22334560 NCBI chr 7:12,899,957...12,905,339
Ensembl chr 7:12,899,958...12,905,339 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CDKN1A mRNA; [cyproconazole co-treated with epoxiconazole] results in decreased expression of CDKN1A mRNA CTD PMID:29038839 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864 		JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 increases expression ISO epoxiconazole results in increased expression of CDS2 mRNA CTD PMID:22334560 NCBI chr 3:124,896,657...124,935,221
Ensembl chr 3:124,896,618...124,935,226 		JBrowse link
G Cebpz CCAAT/enhancer binding protein zeta decreases expression ISO epoxiconazole results in decreased expression of CEBPZ mRNA CTD PMID:22334560 NCBI chr 6:1,516,804...1,534,488
Ensembl chr 6:1,516,804...1,534,488 		JBrowse link
G Ces2c carboxylesterase 2C increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of CES2C mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CES2C mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CES2C mRNA		 CTD PMID:25182419 PMID:29038839 NCBI chr 1:282,640,752...282,648,319
Ensembl chr 1:282,638,017...282,702,424 		JBrowse link
G Ces2h carboxylesterase 2H increases expression ISO epoxiconazole results in increased expression of CES2 mRNA CTD PMID:22334560 NCBI chr19:37,052,555...37,067,176
Ensembl chr19:37,052,556...37,067,156 		JBrowse link
G Cggbp1 CGG triplet repeat binding protein 1 decreases expression ISO epoxiconazole results in decreased expression of CGGBP1 mRNA CTD PMID:22334560 NCBI chr11:1,896,166...1,915,603
Ensembl chr11:1,896,209...1,915,587 		JBrowse link
G Chd1l chromodomain helicase DNA binding protein 1-like increases expression ISO epoxiconazole results in increased expression of CHD1L mRNA CTD PMID:22334560 NCBI chr 2:199,714,044...199,792,270
Ensembl chr 2:199,716,713...199,771,896 		JBrowse link
G Chga chromogranin A multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA CTD PMID:25607892 NCBI chr 6:126,434,226...126,445,569
Ensembl chr 6:126,434,226...126,445,568 		JBrowse link
G Chka choline kinase alpha decreases expression ISO epoxiconazole results in decreased expression of CHKA mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:219,076,618...219,126,221
Ensembl chr 1:219,077,771...219,126,220 		JBrowse link
G Chst1 carbohydrate sulfotransferase 1 decreases expression EXP epoxiconazole results in decreased expression of CHST1 mRNA CTD PMID:25182419 NCBI chr 3:81,441,785...81,512,829
Ensembl chr 3:81,498,022...81,512,807 		JBrowse link
G Cmahp cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene decreases expression ISO epoxiconazole results in decreased expression of CMAH mRNA CTD PMID:22334560 NCBI chr17:42,567,472...42,640,221
Ensembl chr17:42,583,945...42,640,221 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of COMT mRNA CTD PMID:29038839 NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA CTD PMID:29038839 NCBI chr 5:127,505,646...127,523,016
Ensembl chr 5:127,505,614...127,523,089 		JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 increases expression ISO epoxiconazole results in increased expression of CREG1 mRNA CTD PMID:22334560 NCBI chr13:83,972,186...83,984,675
Ensembl chr13:83,972,212...83,984,675 		JBrowse link
G Crp C-reactive protein increases expression ISO epoxiconazole results in increased expression of CRP mRNA CTD PMID:22334560 NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713 		JBrowse link
G Ctsd cathepsin D increases expression ISO epoxiconazole results in increased expression of CTSD mRNA CTD PMID:22334560 NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451 		JBrowse link
G Ctse cathepsin E multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CTSE mRNA CTD PMID:29038839 NCBI chr13:48,426,833...48,449,493
Ensembl chr13:48,426,820...48,449,490 		JBrowse link
G Ctsl cathepsin L increases expression ISO epoxiconazole results in increased expression of CTSL mRNA CTD PMID:22334560 NCBI chr17:1,873,105...1,879,266
Ensembl chr17:1,872,848...1,879,279 		JBrowse link
G Ctso cathepsin O increases expression ISO epoxiconazole results in increased expression of CTSO mRNA CTD PMID:22334560 NCBI chr 2:180,857,178...180,881,677 JBrowse link
G Cyb5a cytochrome b5 type A increases expression ISO epoxiconazole results in increased expression of CYB5A mRNA CTD PMID:22334560 NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CYP11B1 mRNA CTD PMID:28454766 NCBI chr 7:116,248,759...116,255,205
Ensembl chr 7:116,156,219...116,255,167 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 increases expression EXP epoxiconazole results in increased expression of CYP11B2 mRNA CTD PMID:28454766 NCBI chr 7:116,155,928...116,161,781
Ensembl chr 7:116,156,219...116,255,167 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions ISO
EXP		 [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA		 CTD PMID:25233012 PMID:25607892 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions
increases activity		 EXP
ISO		 epoxiconazole results in increased expression of CYP1A1 mRNA
[epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA
epoxiconazole results in increased activity of CYP1A1 protein
epoxiconazole results in increased expression of CYP1A1 mRNA; epoxiconazole results in increased expression of CYP1A1 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [epoxiconazole results in increased expression of CYP1A1 mRNA]; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 protein		 CTD PMID:25182419 PMID:25233012 PMID:29038839 PMID:29294346 PMID:32194361 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression ISO epoxiconazole results in increased expression of CYP1A2 mRNA CTD PMID:22334560 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression
multiple interactions
increases activity		 ISO
EXP		 epoxiconazole results in increased expression of CYP2B10 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP2B1 mRNA
epoxiconazole results in increased activity of CYP2B1 protein
epoxiconazole results in increased expression of CYP2B1 mRNA		 CTD PMID:22334560 PMID:23970803 PMID:25182419 PMID:29038839 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783 		JBrowse link
G Cyp2b15 cytochrome P450, family 2, subfamily b, polypeptide 15 increases expression EXP epoxiconazole results in increased expression of CYP2B15 mRNA CTD PMID:25182419 NCBI chr 1:251,325,923...251,338,404
Ensembl chr 1:251,325,923...251,338,358 		JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of CYP2B2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP2B2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B2 mRNA		 CTD PMID:29038839 NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression
multiple interactions		 ISO epoxiconazole results in increased expression of CYP2B9 mRNA
[fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein		 CTD PMID:22334560 PMID:23970803 PMID:29294346 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615 		JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 increases expression EXP epoxiconazole results in increased expression of CYP2C11 mRNA CTD PMID:29038839 NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434 		JBrowse link
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 increases expression ISO epoxiconazole results in increased expression of CYP2C55 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:258,074,797...258,139,176
Ensembl chr 1:258,074,860...258,139,176 		JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 increases expression
decreases expression		 EXP
ISO		 epoxiconazole results in increased expression of CYP2C6V1 mRNA
epoxiconazole results in decreased expression of CYP2C19 protein		 CTD PMID:25182419 PMID:32194361 NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2E1 mRNA CTD PMID:29038839 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of CYP3A2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A2 mRNA		 CTD PMID:29038839 NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression
multiple interactions
increases activity		 EXP epoxiconazole results in increased expression of CYP3A23-3A1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein; [prochloraz co-treated with cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein
epoxiconazole results in increased activity of CYP3A23-3A1 protein		 CTD PMID:25182419 PMID:29038839 NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136 		JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 increases expression EXP epoxiconazole results in increased expression of CYP4B1 mRNA CTD PMID:25182419 NCBI chr 5:134,508,728...134,526,103
Ensembl chr 5:134,508,730...134,526,089 		JBrowse link
G Cyp51 cytochrome P450, family 51 decreases activity ISO epoxiconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions
decreases expression		 EXP
ISO		 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA
epoxiconazole results in decreased expression of CYP7A1 mRNA		 CTD PMID:29038839 PMID:32194361 NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431 		JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 decreases expression ISO epoxiconazole results in decreased expression of DBT mRNA CTD PMID:22334560 NCBI chr 2:219,563,783...219,592,651
Ensembl chr 2:219,563,783...219,592,650 		JBrowse link
G Dcc DCC netrin 1 receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA CTD PMID:25607892 NCBI chr18:66,518,213...67,629,801
Ensembl chr18:66,523,120...67,224,566 		JBrowse link
G Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit increases expression ISO epoxiconazole results in increased expression of DDOST mRNA CTD PMID:22334560 NCBI chr 5:156,668,924...156,676,036
Ensembl chr 5:156,668,712...156,676,035 		JBrowse link
G Ddx46 DEAD-box helicase 46 decreases expression ISO epoxiconazole results in decreased expression of DDX46 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:9,475,275...9,519,545
Ensembl chr17:9,475,538...9,519,595 		JBrowse link
G Ddx6 DEAD-box helicase 6 decreases expression ISO epoxiconazole results in decreased expression of DDX6 mRNA CTD PMID:22334560 NCBI chr 8:48,924,768...48,961,394
Ensembl chr 8:48,925,604...48,958,026 		JBrowse link
G Dexi Dexi homolog decreases expression ISO epoxiconazole results in decreased expression of DEXI mRNA CTD PMID:22334560 NCBI chr10:5,199,226...5,211,913
Ensembl chr10:5,199,226...5,211,913 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA CTD PMID:29038839 NCBI chr12:38,490,230...38,503,344
Ensembl chr12:38,490,230...38,503,330 		JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase increases expression EXP epoxiconazole results in increased expression of DLAT mRNA CTD PMID:29038839 NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832 		JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA CTD PMID:25607892 NCBI chr11:72,164,566...72,378,895
Ensembl chr11:72,163,749...72,378,895 		JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA CTD PMID:25607892 NCBI chr10:56,625,845...56,655,543
Ensembl chr10:56,627,411...56,653,599 		JBrowse link
G Dlgap3 DLG associated protein 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA CTD PMID:25607892 NCBI chr 5:145,234,757...145,304,536
Ensembl chr 5:145,257,714...145,304,536 		JBrowse link
G Dlgap4 DLG associated protein 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA CTD PMID:25607892 NCBI chr 3:152,752,091...152,846,118
Ensembl chr 3:152,752,091...152,846,118 		JBrowse link
G Dmgdh dimethylglycine dehydrogenase decreases expression ISO epoxiconazole results in decreased expression of DMGDH mRNA CTD PMID:22334560 NCBI chr 2:23,289,376...23,370,360
Ensembl chr 2:23,289,374...23,370,477 		JBrowse link
G Dnai1 dynein, axonemal, intermediate chain 1 decreases expression ISO epoxiconazole results in decreased expression of DNAI1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 5:57,947,796...58,017,985
Ensembl chr 5:57,947,716...58,017,992 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression EXP epoxiconazole results in increased expression of DNAJB1 mRNA CTD PMID:29038839 NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919 		JBrowse link
G Doc2a double C2 domain alpha multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA CTD PMID:25607892 NCBI chr 1:198,282,828...198,288,611
Ensembl chr 1:198,284,473...198,288,113 		JBrowse link
G Dpagt1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 increases expression ISO epoxiconazole results in increased expression of DPAGT1 mRNA CTD PMID:22334560 NCBI chr 8:48,657,779...48,664,531
Ensembl chr 8:48,657,795...48,664,860 		JBrowse link
G Dpp10 dipeptidyl peptidase like 10 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA CTD PMID:25607892 NCBI chr13:39,430,590...41,173,706
Ensembl chr13:39,434,217...39,643,361 		JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA CTD PMID:25607892 NCBI chr 4:4,021,021...4,943,675
Ensembl chr 4:4,021,008...4,473,307 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA CTD PMID:25607892 NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627 		JBrowse link
G Dusp3 dual specificity phosphatase 3 increases expression ISO epoxiconazole results in increased expression of DUSP3 mRNA CTD PMID:22334560 NCBI chr10:89,904,578...89,918,296
Ensembl chr10:89,904,560...89,918,427 		JBrowse link
G Egf epidermal growth factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA CTD PMID:25607892 NCBI chr 2:68,820,616...68,895,537 JBrowse link
G Egfr epidermal growth factor receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA CTD PMID:25607892 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796 		JBrowse link
G Egr1 early growth response 1 decreases expression EXP epoxiconazole results in decreased expression of EGR1 mRNA CTD PMID:28454766 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429 		JBrowse link
G Ehd1 EH-domain containing 1 decreases expression EXP epoxiconazole results in decreased expression of EHD1 mRNA CTD PMID:28454766 NCBI chr 1:221,644,867...221,667,242
Ensembl chr 1:221,644,867...221,667,239 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EHHADH mRNA CTD PMID:29038839 NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of EIF2AK3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EIF2AK3 mRNA		 CTD PMID:29038839 NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694 		JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 decreases expression ISO epoxiconazole results in decreased expression of EIF4G2 mRNA CTD PMID:22334560 NCBI chr 1:175,883,362...175,895,510
Ensembl chr 1:175,883,363...175,895,510 		JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 increases expression ISO epoxiconazole results in increased expression of ELOVL1 mRNA CTD PMID:22334560 NCBI chr 5:137,255,868...137,260,486
Ensembl chr 5:137,255,908...137,260,483 		JBrowse link
G Enho energy homeostasis associated decreases expression ISO epoxiconazole results in decreased expression of ENHO mRNA CTD PMID:22334560 NCBI chr 5:58,018,039...58,019,836
Ensembl chr 5:58,018,039...58,019,836 		JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 increases expression ISO epoxiconazole results in increased expression of ENTPD5 mRNA CTD PMID:22334560 NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EP300 mRNA CTD PMID:29038839 NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression
multiple interactions		 ISO
EXP		 epoxiconazole results in increased expression of EPHX1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of EPHX1 mRNA		 CTD PMID:22334560 PMID:25182419 PMID:29038839 NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579 		JBrowse link
G Ephx2 epoxide hydrolase 2 decreases expression ISO epoxiconazole results in decreased expression of EPHX2 mRNA CTD PMID:22334560 NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA CTD PMID:25607892 NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA CTD PMID:25607892 NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA CTD PMID:25607892 NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644 		JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA CTD PMID:29038839 NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198 		JBrowse link
G Etfa electron transfer flavoprotein subunit alpha decreases expression ISO epoxiconazole results in decreased expression of ETFA mRNA CTD PMID:22334560 NCBI chr 8:60,028,786...60,086,352
Ensembl chr 8:60,028,789...60,086,403 		JBrowse link
G Etnppl ethanolamine-phosphate phospho-lyase decreases expression ISO epoxiconazole results in decreased expression of ETNPPL mRNA CTD PMID:22334560 NCBI chr 2:235,738,377...235,760,351
Ensembl chr 2:235,738,416...235,760,352 		JBrowse link
G Exosc8 exosome component 8 increases expression ISO epoxiconazole results in increased expression of EXOSC8 mRNA CTD PMID:22334560 NCBI chr 2:143,925,643...143,932,240
Ensembl chr 2:143,925,546...143,931,940 		JBrowse link
G F10 coagulation factor X increases expression ISO epoxiconazole results in increased expression of F10 mRNA CTD PMID:22334560 NCBI chr16:81,803,169...81,822,476
Ensembl chr16:81,803,110...81,822,716 		JBrowse link
G F5 coagulation factor V decreases expression ISO epoxiconazole results in decreased expression of F5 mRNA CTD PMID:22334560 NCBI chr13:82,479,997...82,535,540
Ensembl chr13:82,479,998...82,535,534 		JBrowse link
G Fah fumarylacetoacetate hydrolase decreases expression ISO epoxiconazole results in decreased expression of FAH mRNA CTD PMID:22334560 NCBI chr 1:146,713,663...146,736,339
Ensembl chr 1:146,713,676...146,736,261 		JBrowse link
G Fam114a1 family with sequence similarity 114, member A1 increases expression ISO epoxiconazole results in increased expression of FAM114A1 mRNA CTD PMID:22334560 NCBI chr14:44,941,705...45,012,299
Ensembl chr14:44,943,172...45,002,719 		JBrowse link
G Fam168a family with sequence similarity 168, member A decreases expression ISO epoxiconazole results in decreased expression of FAM168A mRNA CTD PMID:22334560 NCBI chr 1:165,723,278...165,880,612
Ensembl chr 1:165,724,451...165,878,652 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of FAS mRNA CTD PMID:29038839 NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790 		JBrowse link
G Fasn fatty acid synthase increases expression EXP epoxiconazole results in increased expression of FASN mRNA CTD PMID:29038839 NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901 		JBrowse link
G Fez2 fasciculation and elongation protein zeta 2 increases expression ISO epoxiconazole results in increased expression of FEZ2 mRNA CTD PMID:22334560 NCBI chr 6:963,903...1,003,955
Ensembl chr 6:963,907...1,004,001 		JBrowse link
G Fgf1 fibroblast growth factor 1 decreases expression ISO epoxiconazole results in decreased expression of FGF1 mRNA CTD PMID:22334560 NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824 		JBrowse link
G Fmr1 FMRP translational regulator 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA CTD PMID:25607892 NCBI chr  X:154,684,924...154,722,369
Ensembl chr  X:154,684,935...154,722,314 		JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA CTD PMID:25607892 NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317 		JBrowse link
G G3bp2 G3BP stress granule assembly factor 2 increases expression ISO epoxiconazole results in increased expression of G3BP2 mRNA CTD PMID:22334560 NCBI chr14:17,437,145...17,523,254
Ensembl chr14:17,492,081...17,520,792 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression ISO epoxiconazole results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213 		JBrowse link
G Gabra4 gamma-aminobutyric acid type A receptor subunit alpha 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA CTD PMID:25607892 NCBI chr14:39,154,072...39,230,994
Ensembl chr14:39,154,529...39,231,695 		JBrowse link
G Gabrb1 gamma-aminobutyric acid type A receptor subunit beta1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA CTD PMID:25607892 NCBI chr14:38,631,192...39,112,598
Ensembl chr14:38,643,385...39,112,600 		JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression ISO epoxiconazole results in increased expression of GADD45B mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322 		JBrowse link
G Gch1 GTP cyclohydrolase 1 increases expression ISO epoxiconazole results in increased expression of GCH1 mRNA CTD PMID:22334560 NCBI chr15:23,935,011...23,968,971
Ensembl chr15:23,934,585...23,969,011 		JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA CTD PMID:25607892 NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238 		JBrowse link
G Ghr growth hormone receptor decreases expression ISO epoxiconazole results in decreased expression of GHR mRNA CTD PMID:22334560 NCBI chr 2:53,149,225...53,413,954
Ensembl chr 2:53,150,370...53,413,638 		JBrowse link
G Glrx glutaredoxin increases expression ISO epoxiconazole results in increased expression of GLRX mRNA CTD PMID:22334560 NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944 		JBrowse link
G Glrx5 glutaredoxin 5 increases expression ISO epoxiconazole results in increased expression of GLRX5 mRNA CTD PMID:22334560 NCBI chr 6:128,750,503...128,760,880
Ensembl chr 6:128,750,795...128,760,880 		JBrowse link
G Gls glutaminase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 NCBI chr 9:54,212,622...54,284,879
Ensembl chr 9:54,212,767...54,284,872 		JBrowse link
G Gls2 glutaminase 2 decreases expression ISO epoxiconazole results in decreased expression of GLS2 mRNA CTD PMID:22334560 NCBI chr 7:2,605,679...2,621,853
Ensembl chr 7:2,605,719...2,621,852 		JBrowse link
G Glud1 glutamate dehydrogenase 1 decreases expression ISO epoxiconazole results in decreased expression of GLUD1 mRNA CTD PMID:22334560 NCBI chr16:10,661,486...10,695,557
Ensembl chr16:10,662,021...10,695,557 		JBrowse link
G Gpc1 glypican 1 decreases expression EXP epoxiconazole results in decreased expression of GPC1 mRNA CTD PMID:28454766 NCBI chr 9:99,998,275...100,026,818
Ensembl chr 9:99,998,275...100,026,818 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression EXP epoxiconazole results in increased expression of GPD1 mRNA CTD PMID:29038839 NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928 		JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA CTD PMID:29038839 NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245 		JBrowse link
G Gpx4 glutathione peroxidase 4 increases expression ISO epoxiconazole results in increased expression of GPX4 mRNA CTD PMID:22334560 NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA CTD PMID:25607892 NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629 		JBrowse link
G Gria4 glutamate ionotropic receptor AMPA type subunit 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA CTD PMID:25607892 NCBI chr 8:1,548,145...2,045,874
Ensembl chr 8:1,548,146...2,045,817 		JBrowse link
G Grik1 glutamate ionotropic receptor kainate type subunit 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA CTD PMID:25607892 NCBI chr11:27,811,954...28,213,940
Ensembl chr11:27,811,957...27,971,359 		JBrowse link
G Grik2 glutamate ionotropic receptor kainate type subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA CTD PMID:25607892 NCBI chr20:53,791,428...54,517,691
Ensembl chr20:53,789,760...54,517,709 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA CTD PMID:25607892 NCBI chr 3:2,507,745...2,534,664
Ensembl chr 3:2,506,896...2,534,663 		JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA CTD PMID:25607892 NCBI chr 4:169,541,620...170,000,216
Ensembl chr 4:169,560,387...169,999,873 		JBrowse link
G Grip1 glutamate receptor interacting protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA CTD PMID:25607892 NCBI chr 7:64,672,723...64,854,939
Ensembl chr 7:64,672,722...64,864,404 		JBrowse link
G Grn granulin precursor decreases expression ISO epoxiconazole results in decreased expression of GRN mRNA CTD PMID:22334560 NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression EXP epoxiconazole results in increased expression of GSR mRNA CTD PMID:25182419 NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression ISO epoxiconazole results in increased expression of GSTA2 mRNA CTD PMID:22334560 NCBI chr 8:85,640,081...85,645,621 JBrowse link
G Gsta5 glutathione S-transferase alpha 5 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of GSTA5 mRNA CTD PMID:29038839 NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179 		JBrowse link
G Gsta6 glutathione S-transferase alpha 6 increases expression ISO epoxiconazole results in increased expression of GSTA2 mRNA CTD PMID:22334560 NCBI chr 9:27,475,273...27,533,939
Ensembl chr 9:27,475,273...27,511,176 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression EXP
ISO		 epoxiconazole results in increased expression of GSTM1 mRNA CTD PMID:22334560 PMID:25182419 NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 increases expression EXP
ISO		 epoxiconazole results in increased expression of GSTM2 mRNA CTD PMID:22334560 PMID:25182419 NCBI chr 2:210,778,041...210,782,807
Ensembl chr 2:210,720,704...210,782,856 		JBrowse link
G Gstm4 glutathione S-transferase mu 4 increases expression ISO epoxiconazole results in increased expression of GSTM4 mRNA CTD PMID:22334560 NCBI chr 2:210,834,013...210,839,242
Ensembl chr 2:210,833,884...210,839,295 		JBrowse link
G Gstm5 glutathione S-transferase, mu 5 increases expression ISO epoxiconazole results in increased expression of GSTM3 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression EXP epoxiconazole results in increased expression of GSTP1 mRNA CTD PMID:25182419 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 increases expression ISO epoxiconazole results in increased expression of GSTT1 mRNA CTD PMID:22334560 NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526 		JBrowse link
G Haao 3-hydroxyanthranilate 3,4-dioxygenase decreases expression ISO epoxiconazole results in decreased expression of HAAO mRNA CTD PMID:22334560 NCBI chr 6:7,045,145...7,059,227
Ensembl chr 6:7,045,152...7,058,314 		JBrowse link
G Hacd1 3-hydroxyacyl-CoA dehydratase 1 increases expression ISO epoxiconazole results in increased expression of HACD1 mRNA CTD PMID:22334560 NCBI chr17:81,173,238...81,196,012
Ensembl chr17:81,173,713...81,187,739 		JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of HADHA mRNA CTD PMID:29038839 NCBI chr 6:27,589,840...27,628,921
Ensembl chr 6:27,589,657...27,629,175 		JBrowse link
G Hal histidine ammonia lyase decreases expression ISO epoxiconazole results in decreased expression of HAL mRNA CTD PMID:22334560 NCBI chr 7:34,326,087...34,356,413
Ensembl chr 7:34,326,087...34,356,413 		JBrowse link
G Hao1 hydroxyacid oxidase 1 decreases expression ISO epoxiconazole results in decreased expression of HAO1 mRNA CTD PMID:22334560 NCBI chr 3:127,444,900...127,500,709
Ensembl chr 3:127,444,902...127,500,709 		JBrowse link
G Hectd1 HECT domain E3 ubiquitin protein ligase 1 decreases expression ISO epoxiconazole results in decreased expression of HECTD1 mRNA CTD PMID:22334560 NCBI chr 6:72,509,658...72,596,285
Ensembl chr 6:72,510,255...72,596,446 		JBrowse link
G Hectd2 HECT domain E3 ubiquitin protein ligase 2 decreases expression ISO epoxiconazole results in decreased expression of HECTD2 mRNA CTD PMID:22334560 NCBI chr 1:255,186,729...255,254,307
Ensembl chr 1:255,185,629...255,254,307 		JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of HERPUD1 mRNA CTD PMID:29038839 NCBI chr19:11,046,905...11,057,440
Ensembl chr19:11,046,909...11,057,254 		JBrowse link
G Hes6 hes family bHLH transcription factor 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HES6 mRNA CTD PMID:25607892 NCBI chr 9:98,549,698...98,551,438
Ensembl chr 9:98,549,705...98,551,438 		JBrowse link
G Higd1c HIG1 hypoxia inducible domain family, member 1C increases expression ISO epoxiconazole results in increased expression of HIGD1C mRNA CTD PMID:22334560 NCBI chr 7:142,000,612...142,021,344
Ensembl chr 7:142,001,338...142,020,705 		JBrowse link
G Hist2h2be histone cluster 2 H2B family member E decreases expression ISO epoxiconazole results in decreased expression of H2BC21 mRNA CTD PMID:22334560 NCBI chr 2:198,360,837...198,363,399
Ensembl chr 2:198,360,998...198,361,378 		JBrowse link
G Hmgn1 high mobility group nucleosome binding domain 1 increases expression ISO epoxiconazole results in increased expression of HMGN1 mRNA CTD PMID:22334560 NCBI chr11:36,474,028...36,479,947
Ensembl chr11:36,474,840...36,479,868
Ensembl chr11:36,474,840...36,479,868 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 increases expression ISO epoxiconazole results in increased expression of HPRT mRNA CTD PMID:22334560 NCBI chr  X:158,196,640...158,228,815
Ensembl chr  X:158,197,149...158,228,749
Ensembl chr  X:158,197,149...158,228,749 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 increases expression EXP epoxiconazole results in increased expression of HSD17B2 mRNA CTD PMID:25182419 NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891 		JBrowse link
G Hspa13 heat shock protein family A (Hsp70) member 13 increases expression ISO epoxiconazole results in increased expression of HSPA13 mRNA CTD PMID:22334560 NCBI chr11:14,146,515...14,160,697
Ensembl chr11:14,144,130...14,160,892 		JBrowse link
G Hspb8 heat shock protein family B (small) member 8 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of HSPB8 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of HSPB8 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of HSPB8 mRNA		 CTD PMID:29038839 NCBI chr12:45,905,371...45,920,014
Ensembl chr12:45,905,371...45,920,013 		JBrowse link
G Ifnar2 interferon alpha and beta receptor subunit 2 increases expression ISO epoxiconazole results in increased expression of IFNAR2 mRNA CTD PMID:22334560 NCBI chr11:31,527,790...31,559,834
Ensembl chr11:31,539,016...31,558,851 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression ISO epoxiconazole results in decreased expression of IGF1 mRNA CTD PMID:22334560 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609 		JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IGF2R mRNA CTD PMID:25607892 NCBI chr 1:48,176,095...48,264,482
Ensembl chr 1:48,176,106...48,264,477 		JBrowse link
G Igfals insulin-like growth factor binding protein, acid labile subunit decreases expression ISO epoxiconazole results in decreased expression of IGFALS mRNA CTD PMID:22334560 NCBI chr10:14,240,308...14,243,554
Ensembl chr10:14,240,219...14,243,597 		JBrowse link
G Ikbke inhibitor of nuclear factor kappa B kinase subunit epsilon increases expression ISO epoxiconazole results in increased expression of IKBKE mRNA CTD PMID:22334560 PMID:23970803 NCBI chr13:48,031,325...48,056,394
Ensembl chr13:48,031,410...48,056,394 		JBrowse link
G Il1rap interleukin 1 receptor accessory protein decreases expression ISO epoxiconazole results in decreased expression of IL1RAP mRNA CTD PMID:22334560 NCBI chr11:77,456,648...77,593,208
Ensembl chr11:77,463,954...77,593,207 		JBrowse link
G Il1rapl1 interleukin 1 receptor accessory protein-like 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of IL1RAPL1 mRNA CTD PMID:25607892 NCBI chr  X:55,439,388...57,004,865
Ensembl chr  X:55,439,578...56,765,893 		JBrowse link
G Impact impact RWD domain protein increases expression ISO epoxiconazole results in increased expression of IMPACT mRNA CTD PMID:22334560 NCBI chr18:4,325,872...4,346,734
Ensembl chr18:4,325,875...4,346,769 		JBrowse link
G Impdh2 inosine monophosphate dehydrogenase 2 decreases expression ISO epoxiconazole results in decreased expression of IMPDH2 mRNA CTD PMID:22334560 NCBI chr 8:117,346,983...117,351,619
Ensembl chr 8:117,347,029...117,351,610 		JBrowse link
G Itgax integrin subunit alpha X multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ITGAX mRNA CTD PMID:29038839 NCBI chr 1:199,555,560...199,576,948
Ensembl chr 1:199,555,722...199,576,932 		JBrowse link
G Itih1 inter-alpha trypsin inhibitor, heavy chain 1 decreases expression ISO epoxiconazole results in decreased expression of ITIH1 mRNA CTD PMID:22334560 NCBI chr16:7,012,376...7,026,542
Ensembl chr16:7,012,354...7,026,540 		JBrowse link
G Itih2 inter-alpha-trypsin inhibitor heavy chain 2 decreases expression ISO epoxiconazole results in decreased expression of ITIH2 mRNA CTD PMID:22334560 NCBI chr17:72,160,734...72,197,248
Ensembl chr17:72,160,735...72,195,509 		JBrowse link
G Itih3 inter-alpha trypsin inhibitor, heavy chain 3 decreases expression ISO epoxiconazole results in decreased expression of ITIH3 mRNA CTD PMID:22334560 NCBI chr16:6,983,779...7,007,288
Ensembl chr16:6,992,062...7,007,287 		JBrowse link
G Itm2c integral membrane protein 2C increases expression ISO epoxiconazole results in increased expression of ITM2C mRNA CTD PMID:22334560 NCBI chr 9:92,916,469...92,930,306
Ensembl chr 9:92,916,469...92,930,279 		JBrowse link
G Ldha lactate dehydrogenase A decreases expression ISO epoxiconazole results in decreased expression of LDHA mRNA CTD PMID:22334560 NCBI chr 1:102,900,288...102,909,713
Ensembl chr 1:102,900,286...102,909,707 		JBrowse link
G Ldlr low density lipoprotein receptor increases expression EXP epoxiconazole results in increased expression of LDLR mRNA CTD PMID:28454766 NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903 		JBrowse link
G Lonrf3 LON peptidase N-terminal domain and ring finger 3 decreases expression ISO epoxiconazole results in decreased expression of LONRF3 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr  X:122,937,987...122,973,289
Ensembl chr  X:122,938,009...122,973,321 		JBrowse link
G Lrat lecithin retinol acyltransferase decreases expression ISO epoxiconazole results in decreased expression of LRAT mRNA CTD PMID:22334560 NCBI chr 2:181,896,304...181,905,366
Ensembl chr 2:181,896,305...181,905,300 		JBrowse link
G Lrrc3 leucine rich repeat containing 3 decreases expression ISO epoxiconazole results in decreased expression of LRRC3 mRNA CTD PMID:22334560 NCBI chr20:11,488,514...11,491,354
Ensembl chr20:11,489,456...11,490,406 		JBrowse link
G Lrrc7 leucine rich repeat containing 7 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of LRRC7 mRNA CTD PMID:25607892 NCBI chr 2:264,910,594...265,300,860
Ensembl chr 2:264,910,594...265,300,868 		JBrowse link
G Lss lanosterol synthase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of LSS mRNA CTD PMID:29038839 NCBI chr20:12,844,522...12,870,474
Ensembl chr20:12,842,884...12,870,497 		JBrowse link
G Luc7l3 LUC7-like 3 pre-mRNA splicing factor decreases expression ISO epoxiconazole results in decreased expression of LUC7L3 mRNA CTD PMID:22334560 NCBI chr10:81,991,147...82,027,119
Ensembl chr10:81,991,147...82,027,119 		JBrowse link
G Maea macrophage erythroblast attacher, E3 ubiquitin ligase increases expression ISO epoxiconazole results in increased expression of MAEA mRNA CTD PMID:22334560 NCBI chr14:82,664,248...82,697,673
Ensembl chr14:82,664,249...82,697,673 		JBrowse link
G Magi2 membrane associated guanylate kinase, WW and PDZ domain containing 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MAGI2 mRNA CTD PMID:25607892 NCBI chr 4:10,995,241...12,472,423
Ensembl chr 4:10,995,234...11,610,518 		JBrowse link
G Magt1 magnesium transporter 1 increases expression ISO epoxiconazole results in increased expression of MAGT1 mRNA CTD PMID:22334560 NCBI chr  X:77,023,423...77,061,603
Ensembl chr  X:77,020,402...77,061,667 		JBrowse link
G Manba mannosidase beta multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA CTD PMID:29038839 NCBI chr 2:240,668,213...240,760,264
Ensembl chr 2:240,668,195...240,760,261 		JBrowse link
G Mbnl2 muscleblind-like splicing regulator 2 increases expression ISO epoxiconazole results in increased expression of MBNL2 mRNA CTD PMID:22334560 NCBI chr15:105,640,097...105,797,933
Ensembl chr15:105,640,097...105,797,932 		JBrowse link
G Mdga2 MAM domain containing glycosylphosphatidylinositol anchor 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MDGA2 mRNA CTD PMID:25607892 NCBI chr 6:88,442,620...89,292,454
Ensembl chr 6:88,447,749...88,917,070 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of MDM2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA		 CTD PMID:29038839 NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328 		JBrowse link
G Meig1 meiosis/spermiogenesis associated 1 increases expression ISO epoxiconazole results in increased expression of MEIG1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:78,813,656...78,829,411
Ensembl chr17:78,817,529...78,829,411 		JBrowse link
G Mesd mesoderm development LRP chaperone increases expression ISO epoxiconazole results in increased expression of MESD mRNA CTD PMID:22334560 NCBI chr 1:146,030,211...146,043,097
Ensembl chr 1:146,037,426...146,043,097 		JBrowse link
G Mettl7a methyltransferase like 7A increases expression ISO epoxiconazole results in increased expression of METTL7A1 mRNA